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ABSTRACT 
 
 
Sleep is an evolutionarily conserved behavior and essential to survival. The 
classic two process model of sleep regulation proposes that sleep results from the 
interaction between circadian and homeostatic processes, but the details remain elusive. 
Most sleep research is performed using nocturnal rodents, and diurnal vertebrates are 
under-represented. It is unclear whether circadian regulatory mechanisms of sleep in 
nocturnal animals can be directly translated into diurnal animals. In this thesis, I first 
briefly describe sleep behavior and the two process model of sleep regulation, focusing 
on the circadian process, and then discuss the advantages of using larval zebrafish as a 
model to study sleep behavior in diurnal vertebrates. In Chapter 2, I characterize the role 
of Prokineticin 2, a proposed circadian output factor in nocturnal animals, in sleep/wake 
regulation in larval zebrafish. I show that, similar to nocturnal rodents, Prok2 is both 
necessary for daytime sleep/wake behavior and sufficient to modulate sleep/wake states 
in a light dependent manner. However, unlike nocturnal rodents and similar to humans, 
Prok2 is not required for maintaining circadian rhythmicity in larval zebrafish after 
removing external light cue. This result demonstrates the potential functional difference 
of circadian output factors in different chronotypes, and establishes larval zebrafish as an 
alternative model for studying circadian regulation of sleep and possibly other behaviors 
in humans. In Chapter 3, I describe the adaptation and development of TRP channels to 
manipulate neuronal activity in larval zebrafish, in an effort to expand the existing 
repertoire of genetic tools for studying behavior in zebrafish. I show that three TRP 
channels, TRPV1, TRPM8 and TRPA1, can inducibly activate specific populations of 
neurons in larval zebrafish by using their appropriate agonists. At high agonist 
 
  viii 
concentrations, TRPV1, can rapidly induce cell ablation. Adaptation of TRP channels for 
use in larval zebrafish expands the variety of behavioral experiments and combinatorial 
manipulation of neuronal activity that can be performed in zebrafish. In summary, this 
work deepens our understanding of sleep regulation, establishes larval zebrafish as an 
appropriate model for studying circadian regulation of sleep in diurnal vertebrates, and 
presents novel genetic tools for studying behavior in larval zebrafish. 
 
  
 
  ix 
TABLE OF CONTENTS 
 
 
Acknowledgements ............................................................................................................ iv 
Abstract ............................................................................................................................. vii 
Table of contents ................................................................................................................ ix 
List of figures and tables .................................................................................................... xi 
Chapter 1: Introduction ....................................................................................................... 1 
1.1 Sleep ..................................................................................................................... 2 
1.2 The two process model of sleep regulation .......................................................... 2 
1.3 Homeostatic process of sleep regulation.............................................................. 3 
1.4 Circadian regulation of sleep ............................................................................... 7 
1.5 SCN projections to sleep-wake centers ................................................................ 9 
1.6 SCN output factors affecting sleep/wake behavior ............................................ 11 
1.7 Regulation of sleep in diurnal vs nocturnal animals .......................................... 14 
1.8 Using larval zebrafish as a model for studying behavior ................................... 15 
1.9 Sleep in larval zebrafish ..................................................................................... 16 
1.10    Outline of the thesis ........................................................................................... 19 
Chapter 2: Light dependent regulation of sleep/wake states by Prokineticin 2 in zebrafish
......................................................................................................................... 20 
2.1      Abstract .............................................................................................................. 21 
2.2      Introduction ........................................................................................................ 22 
2.3      prok2 is expressed in the larval zebrafish ventral hypothalamus ....................... 25 
2.4      prok2 expression does not oscillate in a circadian manner in larval zebrafish .. 28 
2.5      Prok2 overexpression inhibits locomotor activity and promotes sleep during the 
day in zebrafish larvae ....................................................................................... 29 
2.6      Prok2 overexpression phenotype depends on lighting conditions and not 
circadian rhythms ............................................................................................... 32 
2.7      prok2 mutant zebrafish lack overt developmental defects ................................. 35 
2.8      prok2 mutant zebrafish larvae exhibit reduced sleep and hyperactivity during the 
day ...................................................................................................................... 37 
2.9      prok2 mutant larvae do not exhibit attenuated sleep/wake rhythmicity............. 37 
2.10    Zebrafish Prok2 receptors are expressed in discrete brain regions .................... 38 
2.11    Prok2 overexpression-induced sleep/wake phenotypes require Prokr2 but not 
Prokr1 ................................................................................................................. 41 
 
  x 
2.12    Prok2 overexpression phenotype persists in zebrafish containing mutations in 
other sleep regulatory pathways......................................................................... 42 
2.13    Discussion .......................................................................................................... 44 
2.14    Materials and methods ....................................................................................... 50 
Supplemental figures and table ..................................................................................... 57 
Chapter 3: Neuronal activation and ablation in freely behaving zebrafish using TRP 
channels........................................................................................................... 65 
3.1      Abstract .............................................................................................................. 66 
3.2      Introduction ........................................................................................................ 66 
3.3      Expression of heterologous TRP channels in zebrafish sensory neurons induces 
agonist-dependent behavioral phenotypes ......................................................... 69 
3.4      Heterologous TRP channels activate zebrafish sensory neurons in a dose-
dependent manner .............................................................................................. 76 
3.5      Prolonged exposure to high Csn levels causes TRPV1-dependent cell death ... 81 
3.6      Discussion .......................................................................................................... 84 
3.7      Materials and Methods ....................................................................................... 87 
Supplemental figures ..................................................................................................... 93 
Chapter 4: Conclusions and future directions ................................................................... 96 
Conclusions ................................................................................................................... 97 
Future directions .......................................................................................................... 100 
Appendix: Generation of Prok2 and Prok receptor mutants ........................................... 103 
Biblography..................................................................................................................... 109 
  
 
  xi 
LIST OF FIGURES AND TABLES 
 
 
Figure 1.1.   Neural populations that regulate sleep and wakefulness ................................ 6 
Figure 1.2.   Diagram of the mammalian core circadian clock ........................................... 9 
Figure 1.3.   A summary diagram to illustrate the major pathways that translate the output 
from the brain’s biological clock (the SCN) into circadian rhythms of 
sleep/wake cycle .......................................................................................... 13 
Figure 2.1.   prok2 expression in larval zebrafish brain.................................................... 27 
Figure 2.2.   Prok2 overexpression promotes sleep during the day and activity at night 
following daytime heat shock ...................................................................... 31 
Figure 2.3.   Prok2 overexpression promotes sleep during the day and activity at night 
following nighttime heat shock .................................................................... 32 
Figure 2.4.   Prok2 overexpression phenotype depends on lighting condition and not on 
circadian rhythms ......................................................................................... 34 
Figure 2.5.   prok2 mutant larvae are more active during the day .................................... 36 
Figure 2.6.   prok2 mutant larvae exhibit normal sleep/wake rhythmicity ....................... 38 
Figure 2.7.   Expression patterns of prokr1 and prokr2 in larval zebrafish ...................... 40 
Figure 2.8.   Prok2 overexpression phenotype requires Prokr2 ........................................ 42 
Figure S2.1. prok2 expression does not oscillate in circadian manner in larval zebrafish 57 
Figure S2.2. The Prok2 overexpression phenotype depends on lighting condition and not 
on circadian rhythms .................................................................................... 58 
Figure S2.3. prok2 and prok receptor mutants do not show apparent development defects
...................................................................................................................... 59 
Figure S2.4. prok2 receptor mutants lack sleep/wake phenotypes ................................... 60 
Figure S2.5. Prok2 overexpression phenotype does not require Prokr1 ........................... 62 
Figure S2.6. Prok2 overexpression phenotype persists in dbh mutant larvae  ................. 63 
Table S2.1.  List of mutants and small molecules tested for effects on Prok2 
overexpression phenotypes .......................................................................... 64 
Figure 3.1.   Csn induces locomotor activity in embryos expressing TRPV1 in sensory 
neurons ......................................................................................................... 71 
Figure 3.2.   Increased temperatures induce locomotor activity in embryos expressing 
TRPA1 in sensory neurons . ........................................................................ 73 
Figure 3.3.   Menthol induces locomotor activity in embryos expressing TRPM8 in 
sensory neurons ............................................................................................ 75 
Figure 3.4.   Csn activates TRPV1-expressing Rohon-Beard neurons ............................. 78 
Figure 3.5.   Csn can repeatedly induce GCaMP response in TRPV1+ neurons . ............ 80 
 
  xii 
Figure 3.6.   Increased temperature activates TRPA1-expressing Rohon-Beard sensory 
neurons and menthol activates TRPM8-expressing Rohon-Beard neurons .
...................................................................................................................... 81 
Figure 3.7.   High Csn levels ablate TRPV1-expressing Rohon-Beard neurons .............. 83 
Figure 3.8.   High Csn concentration induces cell death  ................................................. 84 
Figure S3.1. Image series showing behavioral response to Csn activation of TRPV1-
expressing sensory neurons at 24hpf. .......................................................... 93 
Figure S3.2. Image series showing behavioral response to thermal activation of TRPA1-
expressing sensory neurons at 48 hpf raised at 22 oC .................................. 94 
Figure S3.3. Image series showing behavioral response to menthol activation of TRPM8-
expressing sensory neurons at 24 hpf .......................................................... 95 
Table A.1.   ZFN target sites for Prok2 and Prok receptors . .......................................... 105 
Table A.2.   TALEN target sites for Prok2 and Prok receptors ...................................... 106 
Table A.3.   Summary of somatic indel rate and germline mutation rate induced by ZFNs 
and TALENs .............................................................................................. 108 
 
   
 
 
 
CHAPTER 1 
 
INTRODUCTION  
 
  2 
1.1 Sleep  
 
Sleep is a conserved behavior observed across the animal kingdom (Zimmerman 
et al., 2008) and is essential for survival (Cirelli and Tononi, 2008). Sleep-like states can 
be defined by a set of behavior criteria (Campbell and Tobler, 1984; Siegel, 2008): 
 A prolonged period of quiescence occurring in specific periods of the circadian 
cycle – in diurnal animals (i.e., humans), sleep usually occurs at night. 
 Elevated sensory arousal threshold – sleeping animals exhibit reduced 
responsiveness to sensory stimuli, which distinguishes sleep from quiet 
wakefulness. This sleep state can be reversed by strong stimuli.  
 Homeostatic regulation – sleep deprived animals exhibit a need for compensatory 
sleep. 
The function of sleep has been postulated from energy conservation and 
physiological restoration to memory consolidation (Mignot, 2008). Over 10% Americans 
suffer from chronic sleep disorders (NHLBI, 2003). However, the genetic and neural 
regulation of sleep behavior still remains largely a mystery (Saper et al., 2005c; Cirelli, 
2009). 
 
1.2 The two process model of sleep regulation 
 
In 1982, Alexander Borbély proposed the “two process model of sleep regulation” 
that has been widely accepted as a conceptual framework of sleep regulation (Borbély, 
1982). According to the model, the architecture of the sleep/wake cycle is determined by 
the interaction between a homeostatic process and a circadian process. The homeostatic 
process responds to the internal need for sleep, and the circadian process is controlled by 
 
  3 
a circadian oscillator that responds to environment cues (i.e. light). In diurnal animals, 
sleep occurs during the night when the circadian drive for waking is low and the internal 
propensity to sleep is high. 
 
1.3 Homeostatic process of sleep regulation 
 
The homeostatic process regulates the internal propensity for sleep, and it 
increases exponentially with the duration of wakefulness and dissipates during sleep 
(Borbély, 1982). The homeostatic regulation of sleep functions independently from the 
circadian regulation because animals with lesions in the suprachiasmatic nucleus (SCN), 
the master circadian clock (see 1.4), continue to sleep and exhibit recovery sleep after 
sleep deprivation (Mistlberger et al., 1983; Tobler et al., 1983).  
 Several molecules have been proposed to mediate the homeostatic regulation of 
sleep. Adenosine, the by-product of the breakdown of adenosine triphosphate (ATP), has 
been identified as a mediator of sleep (reviewed in Bjorness and Greene, 2009). Several 
studies have shown that the adenosine level in the basal forebrain increases with 
prolonged wakefulness (Porkka-Heiskanen et al., 1997, 2000; Murillo-Rodriguez et al., 
2004). Furthermore, adenosine agonists inhibit wake active neurons in the basal forebrain 
(Alam et al., 1999; Thakkar et al., 2003) and hypocretin (Hcrt) neurons in the lateral 
hypothalamus (Liu and Gao, 2007), and activate sleep active neurons in the ventrolateral 
preoptic area (VLPO) (Scammell et al., 2001; Chamberlin et al., 2003; Morairty et al., 
2004; Gallopin et al., 2005; Methippara et al., 2005). Caffeine, a potent stimulant for 
wakefulness, functions as an antagonist of adenosine receptor and exerts its wake 
promoting effects through adenosine A2A receptor (Huang et al., 2005). Nitric oxide 
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(NO) has been shown to stimulate release of extracellular adenosine (Rosenberg et al., 
2000). NO level increases in the basal forebrain upon prolonged wakefulness (Kalinchuk 
et al., 2010) and its production is both required and sufficient to produce sleep 
(Kalinchuk et al., 2006a, 2006b). Pro-inflammatory cytokines such as interleukin-1b and 
tumor necrosis factor-a level correlate with sleep propensity (Bredow et al., 1997; Floyd 
and Krueger, 1997; Taishi et al., 1998). They can increase non-REM sleep, and 
inactivating them reduces sleep (reviewed in Opp, 2005). Prostaglandin D2, a lipid 
signaling molecule, increases with increasing sleep propensity (Ram et al., 1997). 
Infusion of prostaglandin induces sleep (Scammell et al., 1998) possibly via adenosine 
A2A receptor (Satoh et al., 1996, reviewed in Huang et al., 2007). GnRH has been shown 
to enhance sleep in both humans (Kerkhofs et al., 1993) and other mammals (Ehlers et al., 
1986; Obal et al., 1988).  
In addition to the molecules that modulate sleep/wake states of animals, many 
efforts have been put into identifying a neuroanatomical basis of homeostatic regulation 
of sleep (reviewed in Saper et al., 2001). The mammalian sleep and wake promoting 
centers and homologous zebrafish regions are highlighted in Figure 1.1. Sleep promoting 
neurons have been identified in the VLPO (Sherin et al., 1996) and the median preoptic 
nucleus (MnPN) in the preoptic area (Gong et al., 2004). These neurons are primarily 
active during sleep and send inhibitory neurotransmitters GABA and galanin to wake 
promoting neurons (Sherin et al., 1998; Uschakov et al., 2007). The melanin-
concentrating hormone (MCH) neurons in the lateral hypothalamus are active during 
REM sleep and activation of these neurons increases sleep in mice (Verret et al., 2003; 
Konadhode et al., 2013).  In addition, a group of widespread GABAergic interneurons in 
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the cortex expressing nitric oxide synthase are active during slow wave sleep 
(Gerashchenko et al., 2008; Pasumarthi et al., 2010).  
The arousal system consists of the Hcrt neurons in the lateral hypothalamus 
(Peyron et al., 2000; Mileykovskiy et al., 2005), the noradrenergic locus coeruleus in the 
pontine brainstem (Aston-Jones and Bloom, 1981), the dopaminergic neurons in the 
ventral periaqueductal grey matter (Lu et al., 2006), the serotoninergic dorsal raphe 
nuclei in the medial brainstem (McGinty and Harper, 1976), the histaminergic 
tuberomammillary nucleus in the posterior hypothalamus (Parmentier et al., 2002), and 
the cholinergic pedunculopontine and laterodorsal tegmental nuclei in the midbrain 
(Hallanger et al., 1987; McCormick, 1989) and in the basal forebrain (Lee et al., 2005). 
These wake promoting centers inhibit sleep active neurons and send ascending 
projections throughout the cerebral cortex and thalamus to abolish the synchronized low-
frequency rhythms in the thalamocortical system associated with sleep and promote high 
frequency oscillation (Steriade et al., 1993). The mutual inhibition between the wake and 
sleep promoting neurons results in distinct sleep/wake states in animals (Saper et al., 
2005c).  
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Figure 1.1. Neural populations that regulate sleep and wakefulness. A, sagittal view 
of a human brain. B, homologous structures in a sagittal view of larval zebrafish brain. 
Green circles indicated wake-promoting nuclei and red circles indicate sleep-promoting 
nuclei. Abbreviations: VLPO, ventrolateral preoptic nucleus; MnPO, median preoptic 
nucleus; LH, lateral hypothalamus; vPAG, ventral periaqueductal grey; TMN, 
tuberomammillary nucleus; BF, basal forebrain; DR, dorsal raphe nuclei; LC, locus 
coeruleus; LDT, laterodorsal tegmental nucleus; PPT, pedunculopontine nucleus; PO, 
preoptic nucleus; DA, dopaminergic neurons; Ach, cholinergic neurons; OB, olfactory 
bulb; TeO, optic tectum; T, thalamic region; Ce, cerebellum; MO, medulla oblongata. 
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1.4 Circadian regulation of sleep 
 
The circadian regulation of sleep generates an internal sleep/wake rhythmicity 
synchronized to the external environment (e.g. light and availability of food) and ensures 
that sleep occurs at appropriate times (Golombek and Rosenstein, 2010). In mammals, 
the circadian rhythmicity primarily arises from the central circadian clock generated by 
the SCN in the anterior hypothalamus (Klein et al., 1991). The SCN receives direct 
innervations from the eye via the retinohypothalamic tract (Morin and Allen, 2006). In a 
natural environment, it generates a ~24-hour circadian clock according to the Earth’s 
rotation (Panda et al., 2002).   
In 1971, the identification of the period gene in a forward genetic screen in 
Drosophila by Ronald Konopka and Seymour Benzer paved the foundations for the 
molecular basis of circadian clock in animals (Konopka and Benzer, 1971). Subsequent 
characterization of the circadian clock demonstrated that the self-sustained molecular 
oscillator is mediated by a series of interconnected transcriptional autoregulatory 
feedback loops conserved throughout evolution (Reppert and Weaver, 2001). The 
detailed components of the molecular oscillator have been extensively reviewed (Lowrey 
and Takahashi, 2004; Ko and Takahashi, 2006; Partch et al., 2014) and depicted in Figure 
1.2. In mammals, the circadian locomotor cycles kaput (CLOCK) and brain and muscle 
Arnt-like protein-1 (BMAL1) proteins act as major transcriptional activators by forming 
a heterodimer that promotes transcription of Period (Per) and Cryptochrome (Cry) 
(Figure 1.2, Gekakis et al., 1998; Kume et al., 1999). Following translation, PER and 
CRY proteins are phosphorylated by casein kinase 1 ε and δ (CK1). The phosphorylated 
PER and CRY dimerize and translocate back to the nucleus to repress the transcription of 
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Bmal1 and Clock, hence creating a negative feedback loop (Akashi et al., 2002; Lee et al., 
2009). An adjoining negative regulatory loop induced by CLOCK-BMAL1 heterodimers 
is the transcription of retinoic acid-related orphan nuclear receptors, Rev-erbα. Once 
translated, REV-ERBα protein inhibits transcription of Bmal1 by binding retinoic acid-
related orphan receptor response elements (ROREs) in Bmal1 promoter (Triqueneaux et 
al., 2004; Akashi and Takumi, 2005; Guillaumond et al., 2005). 
Each SCN neuron can function as a cell-autonomous oscillator (Welsh et al., 
1995). Synchronization among the SCN cells is essential to produce a robust circadian 
rhythmicity. Synchronization within the SCN is achieved by the release of several 
neurotransmitters in the SCN, including γ-aminobutyric acid (GABA) (Liu and Reppert, 
2000), vasoactive intestinal polypeptide (VIP) (Aton et al., 2005; Maywood et al., 2006), 
gastrin-releasing peptide (GRP) (McArthur et al., 2000; Gamble et al., 2007), and 
vasopressin (AVP) (Maywood et al., 2011), as well as the presence of gap junctions that 
mediate electrical synchronization among SCN neurons (Colwell, 2000; Long et al., 
2005). 
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Figure 1.2. Diagram of the mammalian core circadian clock. Abbreviations: PER (P), 
CRY (Cr), BMAL1 (B), CLOCK (C), CKIε (CKI), REV-ERBα (Rα). Gray diamonds 
represent phosphorylation. (Modified figure from Lowrey and Takahashi, 2004) 
 
 
 
1.5 SCN projections to sleep-wake centers 
 
The major efferent pathway from the SCN is summarized in Figure 1.3. The SCN 
predominantly projects to the subparaventricular zone (SPZ), which is sub-divided into a 
ventral part (vSPZ) located above the SCN, and a dorsal part (dSPZ) located below the 
hypothalamic paraventicular nucleus (PVN) in mammals (Figure 1.3, Watts and Swanson, 
1987; Watts et al., 1987). Lesions to the vSPZ disrupt the circadian regulation of sleep-
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wake and locomotor activity, while lesions of the dSPZ impair circadian rhythm of body 
temperature, suggesting that efferent projection from vSPZ is essential for relaying 
circadian signals to the sleep-wake centers (Lu et al., 2001; Moore and Danchenko, 2002; 
Abrahamson and Moore, 2006).  
The SCN and vSPZ show some direct projection to the sleep and wake promoting 
centers (Sun et al., 2000; Chou et al., 2002; Yoshida et al., 2006), although most of SCN 
projection to the sleep and wake promoting center is mediated through the dorsalmedial 
hypothalamus (DMH), a major target of the vSPZ (Watts, 1991). Lesion of the DMH 
impairs circadian rhythmicity of sleep-wake cycles and locomotor activity (Chou et al., 
2003). DMH then sends mostly GABAergic innervation to the VLPO, and glutamatergic 
and thyrotropin-releasing hormone projections to the Hcrt neurons in the lateral 
hypothalamus (Thompson et al., 1996; Chou et al., 2003). The Hcrt neurons send 
excitatory outputs to the entire monoaminergic arousal system, including the 
histaminerginc TMN, serotoniergic DR, noradrenergic LC, and cholingneric neurons of 
the PPT and basal forebrain (Peyron et al., 1998; Siegel, 2004). These areas then relay 
SCN messages throughout the rest of the brain and peripheral organs that, in turn, 
manifest circadian rhythm in behavior output such as sleep/wake cycle and locomotor 
activity (Saper et al., 2005b).  
The SCN also projects to the pineal gland via a multi-synaptic pathway and 
regulates the level of melatonin, a pineal hormone that signals darkness and promotes 
sleep in diurnal animals (Hardeland, 2008; Fisher et al., 2013; Gandhi et al., 2015). 
Circadian signals from the SCN are transmitted to the paraventricular nuclei of the 
hypothalamus (PVH), intermediolateral nucleus of the spinal cord, superior cervical 
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ganglion (SCG), and then finally the pineal gland (Borjigin et al., 2012). The SCN uses a 
combination of daytime inhibitory and nighttime stimulatory signals to control the daily 
rhythm of pineal melatonin synthesis (Perreau-Lenz et al., 2003). At night, the 
glutamatergic output from the SCN innervating the PVH stimulates the release of 
norepinephrine from the SCG, which acts on beta-adrenergic receptors in the pineal gland 
to increase melatonin synthesis (Perreau-Lenz et al., 2004). During the day, GABAergic 
output from the SCN to PVH inhibits melatonin synthesis (Kalsbeek et al., 2000).  
 
1.6 SCN output factors affecting sleep/wake behavior 
 
In addition to the synaptic transmission and neuroendocrine regulation of 
sleep/wake cycle, the SCN also regulates behavioral state by diffusible factors (Silver et 
al., 1996). In 1996, Silver et al. discovered that preventing axonal outgrowth from SCN 
grafts using a semipermeable polymeric capsule restored circadian rhythmicity in animals 
whose own SCN was ablated.   
So far, four candidate molecules expressed in the SCN have been discovered and 
proposed as circadian output molecules that regulate sleep/wake cycles or locomotor 
activity: transforming growth factor-α (TGF-α) (Kramer et al., 2001), Prokineticin 2 
(PROK2) (Cheng et al., 2002), AVP (Tousson and Meissl, 2004; Li et al., 2009a), and 
cardiotrophin-like cytokine (CLC) (Kraves and Weitz, 2006). 
TGF-α is expressed in a rhythmic fashion in the astrocytes of the SCN with peak 
levels during the day (Kramer et al., 2001; Li et al., 2002). Infusion of TGF-α inhibits 
locomotor activity and disrupts circadian sleep-wake cycle, and the effect is mediated by 
epidermal growth factor receptor (EGFR) in the SPZ. Mice with a hypomorphic EGF 
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receptor mutation show increased daytime locomotor activity, suggesting TGF-α may 
function as a SCN inhibitor of locomotion (Kramer et al., 2001). EGFR’s conservative 
role in sleep regulation has also been described in C. elegans, and Drosophila (Foltenyi et 
al., 2007; Van Buskirk and Sternberg, 2007).  
AVP concentration in the cerebrospinal fluid (Reppert et al., 1981) and in the 
SCN show circadian rhythmicity with a peak at early light phase (Tominaga et al., 1992). 
Its expression in the SCN is activated by the CLOCK-BMAL1 complex (Jin et al., 1999). 
AVP also has a well-established role in circadian regulation of hormone release 
(Kalsbeek et al., 2010). Neither central infusion of vasopressin (Albers et al., 1984), 
vasopressin receptor antagonists (Stoynev and Nagai, 1996), nor loss of AVP 
(Groblewski et al., 1981) changed circadian rhythms in locomotor activity rhythms in 
rodents. However, mice deficient in vasopressin receptor V1a, which is predominantly 
expressed in the SCN, exhibited attenuated circadian rhythmicity of locomotor activity 
(Li et al., 2009a).  
PROK2’s role in regulating sleep/wake behavior is described in detail in chapter 2. 
Briefly, PROK2 expression in the SCN exhibits circadian oscillation with high mRNA 
level during the day and low level at night (Cheng et al., 2002). Infusion of PROK2 at 
night suppresses nocturnal wheel-running activity (Cheng et al., 2002). Prok2 mutants 
show attenuated circadian rhythmicity (Li et al., 2006) and decreased total sleep (Hu et 
al., 2007). 
CLC is expressed in a subpopulation of SCN vasopressin neurons and its 
expression level peaks during the late day in mice (Kraves and Weitz, 2006). Infusion of 
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CLC in the dark phase blocks locomotor activity, while neutralizing CLC receptor with 
antibodies increased locomotor activity in the late day (Kraves and Weitz, 2006). 
To date, diffusible factors that promote arousal and activity have not been 
identified. 
 
 
Figure 1.3. A summary diagram to illustrate the major pathways that translate the 
output from the brain’s biological clock (the SCN) into circadian rhythms of 
sleep/wake cycle. (Modified figure from Saper et al., 2005) 
 
 
 
 
 
  14 
1.7 Regulation of sleep in diurnal vs nocturnal animals 
 
Both diurnal and nocturnal animals have identical central clock and sleep-wake 
components (Caldelas et al., 2003; Saper et al., 2005c; Challet, 2007). Neuronal activity 
of the SCN peaks during the day in both diurnal and nocturnal animals, and the clock 
gene expression in the SCN show similar patterns relative to light and dark phases (Sato 
and Kawamura, 1984; Nunez et al., 1999; Dardente et al., 2002), suggesting there is a 
reversal of the circadian circuitry controlling overt rhythm downstream of the central 
clock. However, the neural basis for the inversion remains unclear. vSPZ has been 
suggested as a candidate site of circadian signal inversion as daily neuronal activity 
pattern in the vSPZ differs in diurnal and nocturnal rats (Schwartz et al., 2004). 
Melatonin, a molecule that is expressed in the darkness in both diurnal and nocturnal 
animals (Hardeland, 2008), has been shown to promote sleep in diurnal animals 
(Goldstein and Pavel, 1981; Mintz et al., 1998; Zhdanova et al., 2001, 2002; Gandhi et al., 
2015) but promote wakefulness (Mendelson et al., 1980) or have no effect on sleep in 
nocturnal rodents (Tobler et al., 1994), suggesting circadian molecules may function 
differently in diurnal vs nocturnal animals. 
Most studies of sleep regulation have focused on nocturnal rodents, leading to an 
under-representation of diurnal animals in the field. In addition, the complexity of the 
mammalian brains have partly hindered the elucidation of genetic and neural mechanisms 
that regulate sleep. To better understand the genetic and neural mechanism of sleep 
regulatory circuitry in humans, a simple diurnal vertebrate model is essential.  
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1.8 Using larval zebrafish as a model for studying behavior 
 
Larval zebrafish has recently emerged as a popular model organism to study 
genetic and neuronal control of behavior, attributed by several unique properties of larval 
zebrafish (Fetcho and Liu, 1998). First, shortly after larval zebrafish hatch, they show 
rapid responses to a range of sensory cues and execute extended behavioral response to 
changes in environment (Guo, 2004; Kalueff et al., 2013). Second, mammalian and 
zebrafish brains are morphologically and molecularly conserved, suggesting that similar 
neural circuits may regulate zebrafish and mammalian behaviors. However, the complex 
neuro-regulatory circuits are much simpler in larval zebrafish (Ekström, 1994; Ma, 1994a, 
1994b; Wullimann et al., 1996; Rink and Wullimann, 2001; Mueller et al., 2004; Prober 
et al., 2006).  Third, zebrafish larvae are transparent, which allows direct observation and 
manipulation of neurons activity by optical and optogenetic tools in live animals (Liu and 
Fetcho, 1999; Higashijima et al., 2003; Portugues et al., 2013). Fourth, zebrafish breed in 
large numbers, enabling high throughput genetic and pharmacological experiments that 
are much more difficult to perform with other vertebrate models (Brockerhoff et al., 1995; 
Gross et al., 2005; Muto et al., 2005; Kokel et al., 2010; Rihel et al., 2010a; Wolman et 
al., 2011). Fifth, zebrafish behaviors can be studied and manipulated by dissolving small 
molecules in water, which can be taken up through the gills or absorbed through the skin 
(Goldsmith, 2004; Peterson and Fishman, 2004; Rihel et al., 2010a). Like other model 
organisms, the zebrafish genome is fully characterized, and recent development in 
genome editing tools such as TALEN and CRISPR allows easy manipulation of the 
zebrafish genome (Sander et al., 2011b; Hwang et al., 2013; Bedell and Ekker, 2015). In 
addition, zebrafish larvae are sustained by a yolk sac for the first week of development, 
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eliminating feeding as a potential confounding variable in behavior experiments (Prober 
et al., 2006). Larval zebrafish combine the relative simplicity of Drosophila and C. 
elegans with behavioral complexity and brain structures that partially resemble mammals, 
making it an attractive model to study behavior. In fact, it has been widely used in 
neurogenetic analysis of behavior including locomotion (Budick and O’Malley, 2000), 
sensory response (Granato et al., 1996; Muto et al., 2005; Emran et al., 2007), escape and 
avoidance (Colwill and Creton, 2011; Pelkowski et al., 2011), circadian and sleep 
(Zhdanova et al., 2001; Hurd and Cahill, 2002; Prober et al., 2006; Gandhi et al., 2015), 
reward (Bretaud et al., 2007), and learning and memory assays (Best et al., 2008; Roberts 
et al., 2013), demonstrating that zebrafish larvae can be a powerful tool for elucidating 
neuronal pathways underlying behavior. 
 
1.9 Sleep in larval zebrafish 
 
Larval zebrafish meet all three behavior criteria for sleep.  
A prolonged period of quiescence occurring in specific periods of the circadian 
cycle - Larval zebrafish display robust sleep/wake behavior starting on the fourth day of 
development (Hurd and Cahill, 2002; Prober et al., 2006). Like humans, zebrafish larvae 
are diurnal and exhibit peak swim activity during the day and sleep-state at night. When 
transferred to constant dark conditions, larval zebrafish maintain circadian oscillation in 
locomotor activity, suggesting that zebrafish larvae have an endogenous circadian rhythm 
controlling behavior (Hurd et al., 1998; Hurd and Cahill, 2002). The core molecular 
machinery of the mammalian circadian clock is also conserved in zebrafish (Vatine et al., 
2011). However, some differences exist between zebrafish larvae and mammals. The 
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zebrafish peripheral clock can be directly entrained by light, likely due to its transparency 
(Whitmore et al., 2000). In addition, zebrafish larvae raised in constant light conditions 
lack overt behavior rhythmicity and oscillation of core clock genes, enabling study of 
sleep behavior in the absence of circadian influence (Hurd and Cahill, 2002; Prober et al., 
2006; Gandhi et al., 2015).  
Elevated sensory arousal threshold – zebrafish larvae in quiescent periods have 
increased arousal threshold. They show reduced responsiveness to mechanical stimuli 
and sudden change in light intensity (Zhdanova et al., 2001; Prober et al., 2006). A sleep-
like state is defined as at least one minute of inactivity in zebrafish larvae because one 
minute or longer inactivity is associated with an increase in arousal threshold (Prober et 
al., 2006).  
Homeostatic regulation – zebrafish larvae deprived of sleep at night by a 
mechanical shaker show a subsequent decrease in locomotor activity accompanied by an 
increased in arousal threshold response to mechanical stimulus (Zhdanova et al., 2001).  
Anatomically, zebrafish larvae possess homologous structures that are known to 
regulate mammalian sleep  (Figure 1.1), including the noradrenergic locus coeruleus 
(Guo et al., 1999), the histaminergic tuberomammillary nucleus (Kaslin and Panula, 
2001), the serotonergic dorsal raphe (McLean and Fetcho, 2004), the dopaminergic 
ventral tegmental area and substantia nigra (Ryu et al., 2007; Sallinen et al., 2009), the 
galaninerigc ventrolateral preoptic area (Podlasz et al., 2012), the hypocretinergic and the 
MCH expressing lateral hypothalamus (Prober et al., 2006; Berman et al., 2009), and 
cholinergic regions (Yokogawa et al., 2007; Hong et al., 2013).  
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Many known mammalian sleep regulators are also conserved in zebrafish larvae, 
but expressed in much fewer cells. For example, loss of neuropeptide Hcrt or its receptor 
causes narcolepsy in humans, dogs, and mice, characterized by fragmented sleep, 
daytime sleepiness, and cataplexy (Zeitzer et al., 2006; Sakurai, 2007). Injection of Hcrt 
peptide promotes locomotor activity and inhibits sleep in rodents (Bourgin et al., 2000). 
Similarly, Hcrt overexpression in zebrafish larvae promotes locomotor activity and 
inhibits sleep (Prober et al., 2006). In addition, like mammals, zebrafish Hcrt neurons 
project to aminergic and cholinergic neurons (Kaslin et al., 2004; Prober et al., 2006; 
Sakurai, 2007). However, unlike the thousands of Hcrt neurons in the mammalian brain, 
zebrafish larvae only have ~10 Hcrt neurons, making it much simpler to study (Prober et 
al., 2006). In addition, melatonin, a pineal hormone that has been shown to promote sleep 
in diurnal mammals, has also been recently demonstrated to promote sleep and is 
required for circadian regulation of sleep in zebrafish larvae (Gandhi et al., 2015).  
 Another distinct advantage of studying sleep in zebrafish larvae is its amenability 
for pharmacological studies. Zebrafish larvae lack a mature blood brain barrier and can 
take up small molecules dissolved in water by gills or through the skin (Peterson and 
Fishman, 2004; Zon and Peterson, 2005; Fleming et al., 2013). Several studies have 
shown that the mammalian sleep/wake neuropharmacology is conserved in zebrafish 
larvae, suggesting that similar mechanisms may regulate sleep in larval zebrafish and 
mammals (Zhdanova et al., 2001; Renier et al., 2007; Rihel et al., 2010a).  
This thesis attempts to use the advantages of larval zebrafish to answer unsolved 
questions in regulation of sleep behavior in diurnal vertebrate and expand the existing 
repertoire of genetic tools to manipulate neuronal activity in zebrafish larvae.  
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1.10 Outline of the thesis 
 
Chapter 2 focuses on the use of larval zebrafish to characterize the role of Prok2 
in sleep regulation in a diurnal vertebrate, attempting to answer the question whether 
studies of circadian output factors in nocturnal animals can be directly translated to 
diurnal animals. I show the first genetic gain of function experiment in Prok2 and that 
Prok2 overexpression is sufficient to induce changes in sleep behavior in a light 
dependent manner via Prok receptor 2. Larval zebrafish with a Prok2 loss of function 
mutation confirm that Prok2 is also necessary for normal sleep behavior during the day in 
larval zebrafish, but not for sleep/wake circadian rhythmicity in free running conditions. 
Generation of loss of function mutants is summarized in Appendix. I then compare the 
functional difference of Prok2 in diurnal vs nocturnal animals and propose larval 
zebrafish as an alternative for studying circadian regulation of sleep in humans. Chapter 3 
focuses on adapting genetic tools to manipulate neuronal activity in larval zebrafish and a 
novel method of using them. I show that three transient receptor potential (TRP) channels, 
TRPV1, TRPM8, and TRPA1, can inducibly activate specific populations of neurons in 
larval zebrafish by using their appropriate agonists. At high concentration of its agonist, 
TRPV1 could also rapidly ablate cells. Combinations of these channels enable the 
manipulation of multiple neuronal groups in larval zebrafish and expand the variety of 
behavior experiments that could be performed.  In chapter 4, I conclude the dissertation 
by summarizing the findings of the previous chapters and proposing future experiments 
for understand Prok2 regulation of sleep/wake cycles, including using TRP channels.   
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CHAPTER 2 
 
LIGHT DEPENDENT REGULATION OF SLEEP/WAKE STATES BY 
PROKINETICIN 2 IN ZEBRAFISH   
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2.1 Abstract 
 
The circadian clock regulates diverse biological processes to ensure they occur at 
appropriate times during the 24 hour day/night cycle. In mammals, the suprachiasmatic 
nucleus (SCN) acts as the master circadian pacemaker to regulate circadian rhythms in 
tissues and cells throughout the animal. While the circadian clock mechanism has been 
described at the molecular level, it remains poorly understood how circadian information 
is transmitted from the SCN to other tissues, or how the circadian clock regulates 
physiological and behavioral processes such as sleep. Several secreted proteins have been 
proposed to act as circadian output molecules that transmit this circadian information. 
However, these proteins have primarily been studied in nocturnal rodents, and their 
functions in diurnal vertebrate animals are largely unknown. Here we describe the role of 
one of these factors, prokineticin 2 (Prok2), in regulating sleep/wake behaviors in the 
zebrafish, a diurnal vertebrate. We show that prok2 is exclusively expressed in the larval 
zebrafish ventral hypothalamus, a potential homolog of the mammalian SCN. We found 
that genetic overexpression of prok2 both increases sleep during the day and decreases 
sleep at night, in a manner that depends on lighting conditions and not the circadian clock. 
These phenotypes require Prok receptor 2, which is expressed in neurons associated with 
arousal, and not Prok receptor 1. Finally, we show that prok2 mutant larvae exhibit 
increased locomotor activity and decreased sleep during the day in light/dark conditions, 
but have normal circadian patterns of locomotor activity and sleep in free-running 
conditions. Our results indicate that Prok2 is not required for the circadian regulation of 
sleep in zebrafish, and rather suggest that Prok2 acts as a homeostatic regulator of 
sleep/wake states.  
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2.2 Introduction 
 
Sleep is a conserved behavior that is observed across the animal kingdom but the 
mechanisms that regulate sleep remain poorly understood (Cirelli, 2009). The classical 
two-process model of sleep regulation (Borbély, 1982) postulates that sleep is regulated 
by two processes. First, a homeostatic process that responds to internal cues of sleep need 
increases during wakefulness and dissipates during sleep. Second, a circadian process 
responds to environmental cues to ensure that sleep occurs at the appropriate time during 
the 24-hour day/night cycle. While the circadian clock mechanism has been described in 
detail at the molecular level (reviewed in Partch et al., 2014), it remains poorly 
understood how the circadian clock regulates physiology and behavior, or how circadian 
information is transmitted from master circadian pacemakers such as the mammalian 
SCN to other tissues. Several secreted factors, including arginine vasopressin (AVP) 
(Brown and Nunez, 1989; Li et al., 2009a), melatonin (Gandhi et al., 2015), 
cardiotrophin-like cytokine (CLC) (Kraves and Weitz, 2006), transforming growth factor 
alpha (TGF-α) (Kramer et al., 2001), and prokineticin 2 (Prok2) (Cheng et al., 2002) have 
been proposed to act as factors that transmit circadian information to regulate behavior 
and physiology. This hypothesis is based on the observation that the circadian clock 
regulates the expression of these factors, and that gain or loss of these factors affects 
processes that are regulated by the circadian clock. However, these factors have primarily 
been studied in nocturnal rodents, and their functions in diurnal vertebrate animals are 
largely unknown. 
Prok2 is a cysteine rich secreted peptide that has diverse biological functions 
(LeCouter et al., 2001; Li et al., 2001, 2009b; Ng et al., 2005; Gardiner et al., 2010). Loss 
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of prok2 results in Kallmann syndrome in humans and rodents, which is characterized by 
hypogonadism and anosmia (Dodé et al., 2006; Matsumoto et al., 2006; Pitteloud et al., 
2007; Cole et al., 2008).  A role for Prok2 in regulating sleep is also supported by several 
studies in nocturnal rodents. First, prok2 mRNA is highly expressed in the rodent SCN 
and oscillates with circadian rhythmicity, with high expression levels during the day and 
low levels at night (Cheng et al., 2002; Ji and Li, 2009; Noonin et al., 2013). This 
expression is regulated by both the endogenous circadian clock and by light (Cheng et al., 
2005; Ren et al., 2011). Consistent with a role for Prok2 as an SCN output factor, one of 
its two receptors, Prok receptor 2 (Prokr2), is expressed in many SCN target nuclei in the 
brain (Cheng et al., 2006; Masumoto et al., 2006; Ji and Li, 2009). Second, 
intracerebroventricular (ICV) injection of Prok2 protein in nocturnal rodents at night, 
when they are primarily awake, suppresses locomotor activity, while mice that lack prok2 
or prokr2 exhibit attenuated rhythmicity of several processes regulated by the circadian 
clock, including locomotor activity, thermoregulation, and circulating corticosteroid and 
glucose levels (Cheng et al., 2002; Li et al., 2006; Prosser et al., 2007). In addition, loss 
of prok2 reduces total sleep and sleep recovery compared to baseline after sleep 
deprivation (Hu et al., 2007). In contrast to studies using nocturnal rodents, a recent study 
of humans with a prok2 loss of function mutation found no abnormalities in several 
processes regulated by the circadian clock, including levels of circulating melatonin and 
cortisol, or body temperature, but did find impaired psychomotor vigilance task 
performance (Balasubramanian et al., 2014). These results suggest that molecules that 
have been identified as circadian output factors such as Prok2 nocturnal animals may not 
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act as such in diurnal animals like humans. As a result, it is important to study the 
functions of these factors in diurnal model organisms. 
Several studies suggest that circadian clock output factors may indeed have 
different functions in nocturnal and diurnal animals. For example, the hormone melatonin 
is produced at night in both nocturnal and diurnal animals, and is thus present during the 
circadian phase when diurnal animals are primarily asleep and nocturnal animals are 
primarily awake (Korf et al., 1998; Kazimi and Cahill, 1999). Melatonin has been shown 
to promote sleep in several diurnal species (Goldstein and Pavel, 1981; Mintz et al., 1998; 
Zhdanova et al., 2001, 2002; Zhdanova, 2005) and is required for the circadian regulation 
of sleep in the diurnal zebrafish (Gandhi et al., 2015), whereas melatonin has been shown 
to be wake-promoting (Mendelson et al., 1980) or to have no effect on sleep (Tobler et al., 
1994) in nocturnal animals. Based on these observations, melatonin is thought to act as a 
hormonal signal for processes specific to the dark phase of the circadian cycle (Turek and 
Gillette, 2004), with different functions in nocturnal and diurnal animals. This distinction 
highlights the need to study circadian clock output factors in diurnal animal models in 
order to understand how they may act in humans. 
Recent studies have shown significant conservation of sleep/wake behaviors in 
simple and genetically tractable model organisms such as C. elegans, Drosophila, and 
Danio rerio (zebrafish) (Shaw et al., 2000; Raizen et al., 2008; Zimmerman et al., 2008; 
Singh et al., 2011). The zebrafish is a diurnal vertebrate that exhibits behavioral, genetic, 
anatomical, and pharmacological conservation of mammalian sleep biology  (Zhdanova 
et al., 2001; Kaslin et al., 2004; Faraco et al., 2006; Prober et al., 2006; Renier et al., 2007; 
Yokogawa et al., 2007; Appelbaum et al., 2009; Rihel et al., 2010a). Because the 
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zebrafish is diurnal, it may be a more relevant model than nocturnal rodents for how the 
circadian clock regulates sleep in humans. To understand the function of a putative 
circadian output factor in regulating sleep in a diurnal vertebrate, here we analyze the 
effects of Prok2 gain- and loss-of-function perturbations on sleep/wake behaviors in 
larval zebrafish.  
 
2.3 prok2 is expressed in the larval zebrafish ventral hypothalamus 
 
Previous studies identified a single zebrafish orthologue of prok2 (Ayari et al., 
2010), but its expression pattern in larvae has not been described. Using in situ 
hybridization (ISH), we found that prok2 is exclusively expressed in a bilateral cluster of 
neurons in the ventral hypothalamus on the fifth day of development (Figures 2.1A, B), a 
similar brain region to the mammalian SCN. Each cluster consists of ~10 neurons and is 
located adjacent to the optic chiasm (Wullimann and Knipp, 2000). Double-fluorescent 
ISH (FISH) revealed that all prok2-expressing neurons express vesicular glutamate 
transporter 1, and thus are glutamatergic (Figures 2.1C-2.1C’’’). A previous study 
reported more widespread prok2 expression in the adult zebrafish brain (Ayari et al., 
2010). Furthermore, in rodents prok2 is expressed in many brain regions in addition to 
the SCN, including the nucleus accumbens, globus pallidus, medial amygdala, medial 
preoptic area, arcuate nucleus, and olfactory bulb (Cheng et al., 2002, 2006). Thus, either 
prok2 expression is more restricted in larval zebrafish than in rodents and adult zebrafish, 
or expression in regions other than the ventral hypothalamus is too weak to detect at 
larval stages. In either case, our data suggest that prok2 is predominantly expressed in the 
ventral hypothalamus in zebrafish larvae. This restricted expression pattern suggests that 
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zebrafish larvae may provide a simpler system to study the role of Prok2 in regulating 
sleep compared to adult zebrafish and rodents. 
Because prok2 is highly expressed in the rodent SCN and has been proposed to be 
a circadian output molecule, we compared prok2 expression with the zebrafish 
orthologues of other mammalian SCN markers using double FISH. In mammals, 
vasoactive intestinal peptide (vip)- and gastrin-releasing peptide (grp)-expressing 
neurons are found in the core of SCN, while arginine vasopressin (avp)-expressing 
neurons are found in the shell of SCN (Masumoto et al., 2006). transforming growth 
factor alpha (tgfα) is expressed throughout the mammalian SCN but is found more 
abundantly in the core (Van Der Zee et al., 2005). prok2 is expressed in both the 
dorsomedial (shell) and ventrolateral (core) SCN, and more than 50% of the prok2-
expressing neurons also express vip, grp, or avp (Masumoto et al., 2006). We observed 
that avp is expressed in the ventral hypothalamus just rostral to prok2, as well as in cells 
ventral to prok2 (Figures 2.1D-2.1D’’’). avp is also expressed in bilateral clusters in the 
neurosecretory preoptic area (NPO) (Figures 2.1H-2.1H’), which corresponds to the 
mammalian paraventricular nucleus of the hypothalamus (Herget and Ryu, 2015). vip is 
expressed in a small bilateral cluster of cells just rostral to prok2, as well as in several 
discrete nuclei in the diencephalon, midbrain, and hindbrain (Figures 2.1E-2.1E’’’, 2.1H-
2.1H’). grp is expressed in two clusters of cells near the NPO in close proximity to avp-
expressing neurons, but rostral and dorsal relative to prok2-expressing neurons (Figures 
2.1E-2.1E’’’, 2.1H-2.1H’). However, we did not observe coexpression of prok2 with avp, 
grp, or vip. tgfα is expressed in a bilateral cluster of cells in the midbrain (Figures 2.1G-
2.1G”’) and in cells along the diencephalic ventricle (Figures 2.1H-2.1H’’’), but is not   
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Figure 2.1. prok2 expression in larval zebrafish brain. (A, B) prok2 mRNA is 
expressed in a bilaterally symmetric cluster of neurons in the ventral hypothalamus that 
each contains about 10 neurons at 5 dpf (A, ventral view; B, lateral view; anterior at left). 
Dashed box indicates the ventral hypothalamic region shown in (C). (C) A 0.46 μm 
confocal section shows that prok2-expressing neurons (green) coexpress vesicular 
glutamate transporter 1 (vglut1) (red). DAPI nuclear staining is shown in blue. One 
representative cell, indicated by arrow, is enlarged in inset. C’’’ shows the orthogonal 
view of (C’’) at the red line. Blue line in C’’’ indicates the z position of C’’. Anterior at 
top. (D-G) Confocal projections show prok2 is expressed caudal to avp- (D) and vip- (E) 
expressing cells in the ventral hypothalamus. grp (F) and tgfα (G) are not expressed in 
the ventral hypothalamus. D’’’, E’’’, F’’’, and G’’’ show the orthogonal projection of 
each confocal stack. Anterior at top. (H) Schematic drawing illustrates relative position of 
prok2, avp, vip, grp, and tgfα expressing neurons in larval zebrafish brain at 5 dpf (A, 
ventral view; B, lateral view, anterior at left). Dashed circles indicate the putative SCN. 
Schematics include expression in brain regions not shown in (C-G). Scale bars: A-B, 100 
μm; C-G, 10 μm.  
 
 
 
expressed in the ventral hypothalamic region. Thus, three out of four mammalian SCN 
markers are expressed in the ventral hypothalamus in close proximity to the optic chiasm 
in larval zebrafish, suggesting that this brain region could be a homolog of the 
mammalian SCN. 
 
2.4 prok2 expression does not oscillate in a circadian manner in larval zebrafish 
 
Using ISH and quantitative reverse-transcription PCR (qRT-PCR), prok2 
transcript level was previously reported to oscillate in a circadian manner in rodents 
(Cheng et al., 2002; Noonin et al., 2013). To test whether prok2 expression oscillates in 
zebrafish larvae, we isolated total RNA from larvae at 6 days post-fertilization (dpf) at 4 
hour intervals over the course of 24 hours, and measured prok2 transcript level using 
qRT-PCR. In contrast to rodents, we did not observe a significant change in prok2 
expression level (Figure S2.1A), whereas expression of the circadian clock gene period3 
oscillated in a circadian manner as expected (Delaunay et al., 2000). Consistent with this 
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result, we did not observe changes in prok2 expression using FISH at multiple circadian 
time points (Figure S2.1B, 2.1C). In contrast to these results, a previous study using qRT-
PCR suggested that prok2 transcript may be elevated at the transition from dark to light 
phase in adult zebrafish (Noonin et al., 2013). However, prok2 is expressed in several 
brain regions in adult zebrafish and it was not determined where this expression change 
occurs. Thus, in contrast to rodents, our results indicate that prok2 expression does not 
oscillate in a circadian manner in zebrafish larvae.  
 
2.5 Prok2 overexpression inhibits locomotor activity and promotes sleep during the 
day in zebrafish larvae  
A previous study showed that ICV infusion of Prok2 protein in nocturnal rats at 
night suppresses locomotor activity. Taken together with the observation that prok2 
expression levels in the SCN are high during the day, when nocturnal rodents are 
primarily asleep, this result can be interpreted to mean that Prok2 normally acts as a 
signal to promote day-specific behaviors. If this “day-specific” hypothesis is correct, 
Prok2 overexpression should promote locomotor activity and/or inhibit sleep in diurnal 
animals. Alternatively, Prok2 may act as a signal for behaviors specific for the inactive 
phase of the 24 hour circadian period. If this “inactive phase” hypothesis is correct, Prok2 
overexpression should promote sleep in diurnal animals. To distinguish between these 
possibilities, we generated transgenic zebrafish in which a heat shock inducible promoter 
regulates expression of the zebrafish Prok2 orthologue (Tg(hsp:Prok2)) and monitored 
the effects of Prok2 overexpression on sleep/wake behaviors using a high throughput 
videotracking assay (Prober et al., 2006). We did not observe any difference in the 
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locomotor activity or sleep between Tg(hsp:Prok2) larvae and their wild type (WT) 
siblings before Prok2 overexpression (Figures 2.2A-2F). However, after heat shock, 
Tg(hsp:Prok2) larvae showed a dramatic decrease in locomotor activity and increase in 
sleep during the day. This phenotype was caused by an increase in both the number 
(Figure 2.2G) and length (Figure 2.2I) of sleep bouts, with a corresponding decrease in 
the length of wake bouts (Figure 2.2K). This result suggests that Prok2 acts as a signal to 
promote inactivity and/or sleep, rather than as a signal for day-specific behaviors, in 
zebrafish larvae. 
 However, we also observed that Prok2 overexpression increased locomotor 
activity and decreased sleep at night (Figures 2.2A, 2.2B, 2.2D, 2.2F). This phenotype 
was caused by a decrease in the length of sleep bouts (Figure 2.2J), with a non-significant 
trend towards longer wake bouts (Figure 2.2L), and is in contrast with a simple “inactive 
phase” role for Prok2. Similarly, ICV infusion of Prok2 at night in nocturnal rodents 
decreased locomotor activity at night but also increased locomotor activity the following 
day (Cheng et al., 2002). The opposite phenotype during the following day was 
hypothesized to be an indirect consequence of Prok2 signaling at night, perhaps due to 
desensitization of Prok2 receptors or a “rebound” in activity following a night of 
decreased activity. However, it is also possible that Prok2 signaling directly promotes 
opposite sleep/wake phenotypes during the day and night, thus acting as a homeostatic 
regulator instead of a simple inactivity inducer. To distinguish between these hypotheses, 
we repeated the behavioral experiment but performed the heat shock at night. Following a 
short recovery period after the heat shock, Prok2-overexpressing larvae exhibited 
increased locomotor activity and decreased sleep at night (Figures 2.3A-2.3F).  
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Figure2. 2. Prok2 overexpression promotes sleep during the day and activity at 
night following daytime heat shock. Heat shock (grey bar) during the day decreases 
locomotor activity during the day (A, C) and increases locomotor activity at night (A, D) 
for Tg(hsp:Prok2) larvae (red) compared to their non-transgenic siblings (blue). Prok2 
overexpression also increases sleep during the day (B, E) and decreases sleep at night (B, 
F). These phenotypes were observed for over 36 hours following heat shock. Increased 
daytime sleep due to Prok2 overexpression results from an increase in the number (G) 
and length (I) of sleep bouts, with a corresponding decrease in the length of wake bouts 
(K). Decreased sleep at night due to Prok2 overexpression results from a decrease in the 
length of sleep bouts (J). Data from one representative experiment (A, B) and five 
experiments combined (C-L) are shown. (C-L) show mean ± SEM. n indicates number of 
larvae analyzed. *p < 0.05, ***p < 0.001 by two-tailed Student’s t test. 
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Figure 2.3. Prok2 overexpression promotes sleep during the day and activity at 
night following nighttime heat shock. Heat shock (grey bar) at night increases 
locomotor activity at night (A, D) and decreases locomotor activity during the day (A, C) 
for Tg(hsp:Prok2) larvae (red) compared to their non-transgenic siblings (blue). Prok2 
overexpression also increases sleep during the day (B, E) and decreases sleep at night (B, 
F). These phenotypes were observed for up to 36 hours following heat shock. Data from 
one representative experiment (A, B) and two experiments combined (C-F) are shown. 
(C-F) show mean ± SEM. n indicates number of larvae analyzed. *p < 0.05, ***p < 
0.001 by two-tailed Student’s t test. Note that (C-F) exclude the first two hours after heat 
shock to allow larvae to recover from the heat shock. Both genotypes slept much more 
during the recovery period. 
 
 
 
Furthermore, Prok2-overexpressing larvae exhibited the opposite phenotype the 
following day (Figures 2.3A-2.3F), similar to the daytime phenotype observed following 
a daytime heat shock (Figure 2.2). These results indicate that Prok2 overexpression 
induces opposite sleep/wake phenotypes during the day and night. 
 
 
2.6 Prok2 overexpression phenotype depends on lighting conditions and not 
circadian rhythms 
The opposite sleep/wake phenotypes induced by Prok2 overexpression during the 
day and night might result from differential effects of the circadian clock or lighting 
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conditions on Prok2 function. To distinguish between these possibilities, we raised and 
tested larvae in either constant light or constant dark from birth, both of which result in 
larvae that lack overt molecular or behavioral circadian rhythms (Hurd and Cahill, 2002; 
Kaneko and Cahill, 2005; Prober et al., 2006; Gandhi et al., 2015). In constant light, 
Prok2 overexpression decreased locomotor activity for at least 36 hours and increased 
sleep for 12 hours (Figures 2.4A-2.4D). The lack of change in sleep after 12 hours could 
be due to a floor effect because both Tg(hsp:Prok2) larvae and their WT siblings slept 
very little in constant light conditions. We observed the opposite phenotype in constant 
dark; Prok2 overexpression increased locomotor activity for 24 hours and decreased sleep 
by ~50% for at least 36 hours (Figures 2.4E-2.4H).  
To confirm the light dependency of Prok2 overexpression phenotype, we also 
raised larvae in normal light and dark condition but removed the external lighting cues 
after Prok2 overexpression. Larvae raised in normal light and dark condition continue to 
exhibit circadian rhythmicity of locomotor activity (Hurd et al., 1998; Hurd and Cahill, 
2002). When given constant light after heat shock, Prok2 overexpression decreased 
locomotor activity for at least 2 days and increased sleep for 16 hours (Figures S2.2A-
2.2F). We observed the opposite phenotype when given constant dark after heat shock; 
Prok2 overexpression increased locomotor activity and reduced sleep for at least 2 days 
(Figures S2.2G-2.2L). Together, these results suggest that the opposite effects of Prok2 
overexpression on sleep/wake behaviors during the day and night are dependent on 
lighting conditions and not interactions with the circadian phase.  
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Figure 2.4. Prok2 overexpression phenotype depends on lighting condition and not 
on circadian rhythms. (A-D) Following heat shock at 5 dpf (grey bar), larvae raised and 
tested in constant light are less active for at least 36 hours (A, C) and sleep more for up to 
16 hours (B, D). (E-F) Following heat shock at 5 dpf (grey bar), larvae raised and tested 
in constant dark are more active for up to 28 hours and sleep less for at least 36 hours. 
Data from one representative experiment (A, B, E, F) and two experiments combined (C, 
D, G, H) are shown. Bar graphs show mean ±  SEM. n indicates number of larvae 
analyzed. *p < 0.05, ***p < 0.001 by two-tailed Student’s t test. Note that (C-F) exclude 
the first two hours after heat shock to allow larvae to recover from the heat shock. *p < 
0.05, **p<0.01, ***p < 0.001 by two-tailed Student’s t test. Note that (C, D, G, H) 
exclude the first four hours after heat shock to allow larvae to recover from the heat 
shock. 
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2.7 prok2 mutant zebrafish lack overt developmental defects 
 
To examine the function of endogenous prok2 in a diurnal animal, we generated 
zebrafish with a predicted null mutation in prok2 (Figure 2.5A). prok2 mutant mice 
exhibit a high rate of embryonic and neonatal lethality, and surviving animals are 
hypoactive and show defective olfactory, reproductive, and gonadotropin releasing 
hormone (GnRH) neuron development (Ng et al., 2005; Dodé et al., 2006; Pitteloud et al., 
2007). We found that prok2-/- zebrafish are viable, fertile, and comparable in appearance 
to their prok2+/- and WT siblings (Figure S2.3A). Furthermore, a prok2+/- incross 
generated progeny of the expected Mendelian ratio (12/45 prok2+/+, 22/45 prok2+/-, and 
11/45 prok2-/-). To investigate whether the zebrafish mutant exhibits developmental 
defects similar to the mouse mutant, we performed ISH using markers for the olfactory 
system (tyrosine hydroxylase 1 (th1) and empty spiracles homeobox 1 (emx1)), and the 
two zebrafish gnrh paralogs, gnrh2 and gnrh3. In contrast to the mouse prok2 mutant, we 
failed to detect abnormal expression of any of these markers, suggesting that the olfactory 
system and gnrh-expressing neurons develop normally in zebrafish prok2-/- mutant 
larvae. (Figure S2.3B). This result accords with our observation that prok2 is only 
expressed in the larval zebrafish ventral hypothalamus (Figures 2.1A, 2.1B), whereas 
prok2 is expressed in many other brain regions in rodents. These results suggest that the 
larval zebrafish prok2 mutant may be more appropriate than the mouse mutant for 
studying the role of Prok2 signaling in sleep, since any mouse sleep phenotypes may be 
complicated by the presence of developmental defects.  
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Figure 2.5. prok2 mutant larvae are more active during the day. (A) The amino acid 
sequences of two zebrafish Prok2 mutant proteins (d1 and d8) generated in this study are 
shown compared to the WT protein. (B-M) During the day, prok2-/- larvae (red) are more 
active (B, D) and sleep less (C, F) compared to their prok2+/- (yellow) and prok2+/+ 
(blue) siblings. This phenotype results from a decrease in the number of sleep bouts (H), 
with a trend towards longer waking bouts (L). Note that this phenotype was observed at 6 
dpf and 7 dpf, but not at 5 dpf. Data from one representative experiment (B, C) and five 
experiments combined (D-M) are shown. Bar graphs show mean ± SEM. n indicates 
number of larvae analyzed. *p < 0.05, **p < 0.01 and ***p < 0.001 by one-way ANOVA 
and Dunnett’s test using comparison to WT.  
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2.8 prok2 mutant zebrafish larvae exhibit reduced sleep and hyperactivity during 
the day 
To determine whether prok2 is required for normal sleep/wake behaviors in larval 
zebrafish, we compared prok2-/- larvae to their prok2+/- and WT siblings (Figures 2.5B, 
2.5C). Larvae of all three genotypes showed similar amounts of locomotor activity and 
sleep at night (Figures 2.5B, 2.5C, 2.5E, 2.5G). In contrast, prok2-/- larvae exhibited 
increased locomotor activity and decreased sleep compared to sibling controls during the 
day at 6 and 7 dpf (Figures 2.5B, 2.5C, 2.5D, 2.5F). The increase in activity and decrease 
in sleep during the day was primarily caused by a decreased number of sleep bouts 
(Figure 2.5H), with little or no effect on the length of sleep or wake bouts (Figures 2.5J, 
2.5L). These results indicate that Prok2 is required to maintain normal daytime 
sleep/wake levels. Based on our gain- and loss-of-function results, we propose that Prok2 
may act as a homeostatic regulator of sleep/wake states that opposes the predominant 
behavioral state during the day and at night (see discussion). 
 
 
2.9 prok2 mutant larvae do not exhibit attenuated sleep/wake rhythmicity 
 
prok2 mutant mice are reported to have attenuated rhythmicity of several 
processes regulated by the circadian clock, including locomotor activity, core body 
temperature, and circulating glucose and cortisol levels (Li et al., 2006). To test whether 
prok2 is required for the circadian regulation of locomotor activity and sleep in zebrafish 
larvae, we entrained prok2-/- and their sibling controls in 14:10 hour light:dark condition 
for 5 days and then monitored their behavior in free-running constant dark conditions 
(Figures 2.6A-2.6F). We found that the amount and timing of locomotor activity and 
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sleep was indistinguishable for all three genotypes, indicating that prok2 is not required 
for the circadian regulation of locomotor activity or sleep in zebrafish larvae. This result 
is consistent with the observation that humans lacking prok2 have normal circadian 
rhythmicity of body temperature and circulating cortisol and melatonin levels 
(Balasubramanian et al., 2014). 
 
 
 
Figure 2.6. prok2 mutant larvae exhibit normal sleep/wake rhythmicity. Larvae 
entrained in 14:10 hour light:dark conditions for 5 days and then monitored in constant 
dark maintained normal circadian rhythms of locomotor activity (A, C, D) and sleep (B, 
E, F), with no significant differences between prok2-/-, prok2+/-, or prok2+/+ siblings. 
Data from 2 experiments combined are shown. Bar graphs show mean ±  SEM. n 
indicates number of larvae analyzed. 
 
 
 
2.10 Zebrafish Prok2 receptors are expressed in discrete brain regions  
 
The mammalian genome contains two Prok2 receptors, Prokr1 and Prokr2, that 
have similar affinities for Prok2 in vitro (Lin et al., 2002). The zebrafish genome contains 
two Prokr paralogs, designated prokr1a (ENSDARG00000074182) and prokr1l 
(ENSDARG00000090315) (Figures S2.4A, S2.4B). Zebrafish Prokr1a protein is 62% 
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and 59% identical to mouse Prokr1 and Prokr2, respectively. Zebrafish Prokr1l protein is 
66% and 69% identical to mouse Prokr1 and Prokr2, respectively.  
To determine the expression patterns of these receptors in larval zebrafish, we 
performed ISH using animals fixed at 24 hours post-fertilization (hpf) and 5 dpf. We 
found that prokr1 is expressed in a row of cells along the spinal cord and in a bilateral 
cluster of cells in the ventral hypothalamus (Figures 2.7A, 2.7A’). In contrast, prokr2 is 
expressed in several discrete clusters of cells in the telencephalon, thalamus, 
hypothalamus, tuberomammillary nucleus, locus coeruleus, and medulla oblongata at 5 
dpf (Figures 2.7B-2.7B’’) In rodents, prokr2 mRNA is widely detected throughout the 
brain, including in regions known to regulate sleep, such as the hypothalamus, 
periaqueductal grey, dorsal raphe, and mammillary nuclei (Masumoto et al., 2006). 
prokr1 is expressed in a more restricted pattern in the mouse, including the olfactory 
region, dentate gyrus, zona incerta and dorsal motor vagal nucleus (Masumoto et al., 
2006). Based on expression pattern similarities, we refer to zebrafish prokr1a as prokr1 
and prokr1l as prokr2. 
To characterize prokr2-expressing cells, we performed double FISH using probes 
specific for prokr2 and markers for neurotransmitter and neuromodulator cell types. We 
observed that prokr2-expressing cells in the telencephalon are GABAergic (Figures 2.7E-
2.7E’’), while a bilateral cluster in the thalamic region (Wullimann and Knipp, 2000) is 
glutamatergic (Figures 2.7C-2.7C’’). All prokr2-expressing cells in the locus coeruleus 
and medulla oblongata express vesicular monoamine transporter (vmat)-EGFP (Figures 
2.7D-2.7D’’, 2.7F-2.7F’’), and thus are noradrenergic (Wen et al., 2008). Approximately 
30% of prokr2-expressing cells in the tuberomammillary nucleus express histidine  
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Figure 2.7. Expression patterns of prokr1 and prokr2 in larval zebrafish.  prokr1 is 
expressed in a row of neurons in the spinal cord at 24 hpf (A, enlarged in inset), and in a 
bilateral cluster of cells in the ventral hypothalamus at 5 dpf (A’). prokr2 is expressed in 
discrete clusters of cells in the hindbrain (B), midbrain (B’), and forebrain (B’’) at 5 dpf. 
Arrows indicate domains of prokr2-expressing cells that are shown at higher 
magnification in the indicated panels. Dorsal (B) and ventral (A’, B’, B”) views are 
shown. (B’) and (B”) show dorsal and ventral optical sections, respectively. Rostral at top. 
0.46 μm confocal sections show that prokr2-expressing neurons in the thalamic region 
expresses vesicular glutamate transporter 2b (vglut2b) (C) and prokr2-expressing 
neurons in the forebrain expresses glutamate decarboxylase (gad65 and gad67 probes 
combined) (F). Confocal projections show that prokr2-expressing neurons in the locus 
coeruleus (D) and medulla oblongata (F) expresses vesicular monoamine transporter 
(vmat), which labels noradrenergic neurons in these brain regions. Approximately 30% of 
prokr2-expressing neurons in the tuberomammillary nucleus expresses histidine 
decarboxylase (hdc) (G), a marker of histamine neurons. C’’’, D’’’, E’’’, F’’’, and G’’’ 
show the orthogonal view of C’’, D’’, E’’, F’’, and G’’ at the red line, respectively. Blue 
lines in C’’’ and E’’’ indicate the z-position in C’’ and E’’, respectively. Arrows in (C-G) 
indicate representative neurons. Scale bars: A-B, 100 μm; C-G, 10 μm. 
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decarboxylase (hdc), and thus are histaminergic (Figures 2.7G-2.7G’’). Thus, prokr2 is 
expressed in both GABAergic and glutamatergic cell types in the larval zebrafish brain, 
including in brain regions that are thought to promote arousal. 
 
2.11 Prok2 overexpression-induced sleep/wake phenotypes require Prokr2 but not 
Prokr1 
in vitro experiments have shown that mammalian Prok2 has similar binding 
affinity for both Prokr1 and Prokr2 (Lin et al., 2002); however, potential roles for these 
receptors in Prok2 signaling in vivo have not been tested. To determine whether these 
receptors are required for Prok2 signaling in vivo, we generated zebrafish with predicted 
null mutations in prokr1 and prokr2 (Figures S2.4A, S2.4B). Like the zebrafish prok2 
mutant, prokr1 and prokr2 single and double mutant zebrafish are homozygous viable 
and fertile and lack overt developmental defects (Figures S2.3A, S2.3B). We found that 
the Prok2 overexpression phenotype was abolished in prokr2-/- larvae (Figure 2.8A-2.8F), 
but was unaffected in prokr1-/- larvae (Figure S2.5A-2.5F). These results indicate that 
Prok2 overexpression-induced effects on sleep/wake behaviors require prokr2 but not 
prokr1. In contrast to the zebrafish prok2 mutant, prokr1 and prokr2 single and double 
mutants exhibited normal sleep/wake behaviors (Figures S2.4C-S2.4T), suggesting that 
there may be other endogenous ligands for these receptors.  
 
 
  42 
 
 
Figure 2.8. Prok2 overexpression phenotype requires Prokr2. Following heat shock 
(grey bar in A, B), Prok2 overexpression-induced locomotor activity (A, C, D) and sleep 
(B, E, F) phenotypes are abolished in prokr2-/- larvae (yellow), but not prokr2+/- larvae 
(red). Data from two experiments are shown. Bar graphs show mean ± SEM. n indicates 
number of larvae analyzed. *p< 0.05, **p < 0.01, ***p < 0.001 by two-way ANOVA and 
Tukey’s multiple comparison test. 
 
 
 
2.12 Prok2 overexpression phenotype persists in zebrafish containing mutations in 
other sleep regulatory pathways 
In an attempt to identify the genetic mechanisms throughout which Prok2 
signaling affects sleep/wake behaviors, we tested whether the Prok2 overexpression 
phenotypes are suppressed in larvae containing mutations in genes implicated in 
regulating sleep. Based on our observations that Prok2 overexpression-induced 
phenotypes require prokr2 (Figure 2.8), and that prokr2 is expressed in noradrenergic 
(NA) neurons in the locus coeruleus and medulla oblongata (Figures 2.7D-2.7D’’, 2.7F-
2.7F’’), we hypothesized that Prok2-induced phenotypes might require NA. For example, 
Prok2 overexpression might promote daytime sleep by inhibiting NA signaling, and 
conversely might inhibit sleep at night by stimulating NA signaling. To test this 
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hypothesis, we overexpressed Prok2 in larvae containing a null mutation in dopamine 
beta hydroxylase (dbh), which lack noradrenaline and exhibit reduced locomotor activity 
and increased sleep (Singh et al., submitted)(Figures S2.6A, S2.6B). During the day, 
Prok2 overexpression further reduced locomotor activity and increased sleep in dbh-/- 
larvae compared to their dbh+/- siblings (Figures S2.6A-S2.6C, S2.6E). At night, Prok2 
overexpression significantly decreased sleep in dbh-/- larvae and showed a trend toward 
increased activity (Figures S2.6A, S2.6B, S2.6D, S2.6F). The lack of a different Prok2 
overexpression phenotype for dbh-/- compared to dbh+/- larvae at 5 dpf may be due to a 
floor effect, as the magnitude of difference between Tg(hsp:Prok2);dbh-/-  and 
Tg(hsp:Prok2); dbh+/- larvae is comparable to that between dbh-/-  and dbh+/- larvae on 
the following day. Based on these results, we conclude that Prok2 overexpression-
induced sleep/wake phenotypes do not require NA. 
We further tested whether the Prok2 overexpression phenotype is blocked in 
zebrafish containing mutations that affect other known sleep regulatory pathways or 
using small molecule regulators of these pathways (Table S1). We tested zebrafish with 
mutations in hdc (Chen and Prober, unpublished), tryptophan hydroxylase 2 (tph2) 
(Oikonomou and Prober, unpublished), arylalkylamine N-acetyltransferase 2 (aanat2) 
(Gandhi et al., 2015) , hypocretin receptor (Yokogawa et al., 2007), or glucocorticoid 
receptor (Ziv et al., 2013), which lack histamine, serotonin in the dorsal raphe, melatonin, 
hypocretin signaling, and glucocorticoid signaling, respectively. We also tested the 
dopamine receptor 1 antagonist SCH23390 (Monti et al., 1990) and exogenous 
melatonin(Gandhi et al., 2015). None of these mutations or small molecules blocked the 
Prok2 overexpression phenotype (data not shown), suggesting that none of these 
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pathways is necessary for the effects of Prok2 overexpression on sleep/wake states. 
While we cannot rule out the possibility that Prok2-induced phenotypes act via more than 
one of these pathways, which must be blocked simultaneously to inhibit the effects of 
Prok2 overexpression, these results suggest that Prok2 affects sleep via other mechanisms.  
 
2.13 Discussion 
 
Prok2 has been proposed to act as a circadian output molecule that affects 
locomotor activity in nocturnal rodents (Cheng et al., 2002; Zhou and Cheng, 2005). 
However, it is unclear how the functions of Prok2 specifically, and circadian output 
factors in general, that were identified in nocturnal animals can be translated to diurnal 
animals. Here we describe the first diurnal vertebrate genetic gain- and loss-of-function 
models for Prok2 and use them to investigate the function of Prok2 in regulating diurnal 
sleep/wake behaviors. In nocturnal rodents, Prok2 expression oscillates in the SCN in a 
circadian manner with high levels during the day, and ICV infusion of Prok2 at night 
decreases locomotor activity (Cheng et al., 2002). Based on these observations, it was 
unclear whether Prok2 acts a behavioral signal that promotes inactivity or behaviors 
specific to the light phase (Cheng et al., 2002). We found that overexpressing Prok2 
during the day in zebrafish larvae inhibits locomotor activity and promotes sleep, 
suggesting that Prok2 acts as a signal to promote inactivity and not for day-specific 
behaviors. In addition to inhibiting locomotor activity at night in nocturnal rodents, Prok2 
infusion at night also resulted in increased locomotor activity the following day. While 
this phenotype was interpreted to be a consequence of reduced nighttime activity, we 
found that inducing Prok2 overexpression at night in larval zebrafish almost immediately 
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resulted in increased locomotor activity and decreased sleep. This observation suggests 
that Prok2 directly promotes both sleep during the day and activity at night. Surprisingly, 
we found that these opposite day/night behavioral phenotypes do not require circadian 
rhythms, but rather depend on lighting conditions, suggesting that Prok2 acts as a signal 
for light/dark cues, rather than day/night circadian cues.  
Based on our observations, we propose a model in which Prok2 signaling acts as a 
homeostatic regulator of sleep/wake states that opposes the predominant behavioral state 
during light and dark periods. Thus, Prok2 overexpression in light, when diurnal animals 
are active and nocturnal animals are inactive, promotes inactivity in diurnal animals and 
activity in nocturnal animals. Similarly, Prok2 overexpression in dark, when diurnal 
animals are inactive and nocturnal animals are active, promotes activity in diurnal 
animals and inactivity in nocturnal animals. If this hypothesis is correct, diurnal prok2 
mutants should be more active during the day and less active at night. Indeed, we found 
that prok2 mutant zebrafish larvae are more active and sleep less during the day. 
Similarly, prok2 mutant nocturnal rodents also exhibit decreased sleep during the day (Li 
et al., 2006; Hu et al., 2007), suggesting that a role for endogenous Prok2 in regulating 
daytime sleep/wake behaviors may be conserved in diurnal and nocturnal vertebrates. 
However, inconsistent with our model, loss of prok2 does not affect sleep/wake states at 
night in either zebrafish or rodents (Li et al., 2006; Hu et al., 2007). Thus, endogenous 
Prok2 may only regulate sleep/wake states during the day. Alternatively, because the 
zebrafish Prok2 overexpression phenotype at night is much weaker than the daytime 
phenotype, our behavioral assay may not be sensitive enough to detect a subtle nighttime 
prok2 mutant phenotype. The lack of a nighttime phenotype in prok2 mutants could also 
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result from redundant sleep-regulating mechanisms at night or developmental 
compensation for the loss of prok2 that only rescues its nighttime function.  
Previous studies showed that loss of Prok2 or Prokr2 in nocturnal rodents led to 
attenuated circadian rhythmicity, as measured by core body temperature, and circulating 
glucose and cortisol levels (Li et al., 2006; Prosser et al., 2007), as well as decreased 
daytime sleep. However, we found that circadian rhythmicity of locomotor activity and 
sleep was normal in larval zebrafish prok2 mutants. This results suggests that Prok2 may 
not be required for the circadian regulation of sleep/wake behaviors in diurnal animals, 
consistent with the finding that melatonin is essential for the circadian regulation of sleep 
in zebrafish larvae (Gandhi et al., 2015). Alternatively, Prok2 function may differ in 
diurnal zebrafish and diurnal mammals. Further studies are required to determine whether 
other behavioral and physiological processes that are regulated by the circadian clock are 
compromised in zebrafish prok2 mutants. 
A potentially important difference between larval zebrafish and both nocturnal 
and diurnal rodents is that prok2 expression oscillates in a circadian manner in the rodent 
SCN (Cheng et al., 2002), but we failed to detect any significant change in larval 
zebrafish prok2 expression throughout the circadian cycle. It is unknown whether prok2 
expression oscillates in the human SCN. Thus, it is unclear whether circadian oscillation 
of prok2 expression is unique to rodents, or whether prok2 expression is differentially 
regulated in mammals and zebrafish. The latter possibility is consistent with the 
observation that the circadian clock of each larval zebrafish cell can be directly entrained 
by light (Whitmore et al., 2000) due to the presence of D and E boxes in the promoter of 
period2 gene (Vatine et al., 2009). Because zebrafish larvae are optically transparent, it 
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may not be necessary for prok2 expression to be regulated by the circadian clock, and it 
is unknown whether zebrafish larvae possess a master circadian pacemaker analogous to 
the mammalian SCN. Consistent with this hypothesis, prok2 expression may oscillate in 
adult zebrafish (Noonin et al., 2013), which are no longer transparent, although the 
reported oscillation was not very robust. Furthermore, prok2 is apparently expressed in 
several brain regions in adult zebrafish and it is unknown where this oscillation may 
occur. Analysis of prok2 expression in additional species is needed to address this 
question. 
Another distinction between rodents and zebrafish larvae is that prok2 is 
expressed in many brain regions in addition to the SCN in rodents, including the nucleus 
accumbens, globus pallidus, medial amygdala, medial preoptic area, arcuate nucleus, and 
olfactory bulb (Cheng et al., 2002, 2006), which are involved in many biological 
processes. Accordingly, prok2 mutant rodents suffer from embryonic and neonatal 
lethality as well as defects in the olfactory and reproductive systems. These defects may 
account for the reduced rhythmicity of processes regulated by the circadian clock in 
prok2 mutant rodents. In contrast, prok2 is exclusively expressed in the larval zebrafish 
ventral hypothalamus near the optic chiasm, a brain region similar to the mammalian 
SCN. This restricted expression pattern likely explains the lack of developmental defects 
in zebrafish prok2 mutants, and may also account for the attenuated locomotor rhythms 
observed in the mouse mutant, but not the zebrafish mutant, in free-running conditions. 
Larval zebrafish may thus provide a simpler system to study the role of Prok2 in 
regulating sleep and circadian processes due to its restricted expression domain. The 
zebrafish prok2 mutant phenotype also bears similarities to humans, as patients with 
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prok2 mutations exhibit normal circadian rhythmicity of melatonin, cortisol and core 
body temperature (Balasubramanian et al., 2014), but exhibit sleep defects (Dodé et al., 
2006; Cole et al., 2008). These data agree with our observation that prok2 mutant larval 
zebrafish exhibit abnormal sleep/wake behaviors but lack changes in free-running 
circadian rhythmicity, suggesting that larval zebrafish, being a diurnal vertebrate, may be 
a more relevant model than nocturnal rodents for studying Prok2 regulation of sleep in 
humans.  
Previous studies identified two GPCRs, Prokr1 and Prokr2, that bind Prok2 with 
similar affinity in vitro (Lin et al., 2002). Prokr2 was suggested to be the endogenous 
receptor for Prok2 based on its expression in SCN target regions in rodents (Cheng et al., 
2002), but this hypothesis has not been tested. We found that Prok2 overexpression 
phenotypes are abolished in prokr2, but not prokr1, mutant larvae, consistent with the 
hypothesis that Prokr2 mediates the effects of Prok2 on sleep/wake behaviors in vivo. 
Despite the sleep phenotype observed in prok2 mutant zebrafish larvae, we failed to 
detect sleep defects in either single or double prokr1 and prokr2 mutants. This 
discrepancy suggests that there may be additional receptors for Prok2 that are not 
required for Prok2 overexpression phenotypes but are sufficient to maintain normal 
sleep/wake behaviors in the absence of prokr1 and prokr2. Alternatively, there may be 
other ligands for these receptors that have opposite effects on sleep as Prok2.  
In larval zebrafish, prokr2 is expressed in several known sleep/wake centers, 
including locus coeruleus noradrenergic (NA) neurons and tuberomammillary nucleus 
histaminergic (HA) neurons. Prokr2 is not expressed in these regions in the rodent brain, 
suggesting that Prok2 signaling may act via different neuronal mechanisms in nocturnal 
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and diurnal animals. Alternatively, the simpler brain structure of zebrafish larvae or their 
diurnal nature may account for these differences. For example, nocturnal rodents may 
require an intermediate step between Prok2 output from the SCN to these sleep regulating 
centers. For example, in rodents, Prokr2 is expressed in the dorsomedial hypothalamic 
nucleus and amygdala, both of which innervate the locus coeruleus (Aston-Jones et al., 
2001; Bouret et al., 2003; Zhou and Cheng, 2005; Cheng et al., 2006).  
Even though prokr2 is expressed in NA and HA neurons in larval zebrafish, the 
Prok2 overexpression phenotype persisted in mutants that lack NA or HA, suggesting 
that Prok2 does not affect sleep via these neuromodulators. The Prok2 overexpression 
phenotype was also unaffected in larvae that lack serotonin in the dorsal raphe, 
hypocretin signaling or glucocorticoid signaling, or in larvae treated with a dopamine 
receptor 1 antagonist. It remains possible that it is necessary to block more than one of 
these pathways simultaneously to inhibit the effects of Prok2 overexpression on sleep. 
Alternatively, Prok2 may act via known sleep regulatory pathways that we did not test or 
via unknown sleep regulators. The opposite phenotypes of Prok2 overexpression in light 
and dark suggests that factors that are differentially regulated by lighting conditions play 
a key role in determining the effects of Prok2 signaling on sleep. A good candidate factor 
is melatonin, whose synthesis is restricted to the night and is rapidly inhibited by light 
(Klein, 2007), but we found that neither depletion of endogenous melatonin nor addition 
of exogenous melatonin blocked the Prok2 overexpression phenotypes. It may 
nevertheless be useful to identify additional such factors and determine whether they 
modulate the effects of Prok2 signaling.  
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In summary, we have shown how a circadian clock output factor identified in 
nocturnal rodents affects sleep/wake behaviors in a diurnal vertebrate. Our results are 
consistent with observations in humans containing prok2 mutations, suggesting that 
larval zebrafish may be more appropriate than nocturnal rodents as a model to understand 
how Prok2 regulates sleep in humans. It will be useful in the future to determine whether 
our findings are broadly applicable to other such factors, and thus reveal general 
principles for how observations in nocturnal animals may be translated to diurnal animals. 
 
2.14 Materials and Methods 
 
Ethics statement 
Zebrafish experiments and husbandry followed standard protocols (Westerfield, 1993) in 
accordance with Caltech Institutional Animal Care and Use Committee guidelines.  
 
Transgenic and mutant zebrafish 
Heat-shock promoter regulated Prok2 (Tg(hsp:Prok2)). Full-length zebrafish prok2 
cDNA was cloned downstream of the zebrafish hsp70c promoter (Halloran et al., 2000) 
in a vector containing flanking I-SceI endonuclease recognition sites. Stable transgenic 
fish were generated by injecting plasmids with I-SceI into zebrafish embryos at the one-
cell stage. Transgenic founders were identified by outcrossing potential founders, heat 
shocking progeny at 5 dpf, fixing larvae 30 minutes after heat shock and performing ISH 
using a prok2-specific probe. 
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Zebrafish mutants were generated using the TAL effector nuclease (TALEN) method as 
described (Reyon et al., 2012) using plasmids obtained from Addgene. 
 
prok2 mutant. TALEN target sites were 5’-TGGCATGTGTTGTGCAGT-3’ and 5’-
TGCACATTCGGAGACT-3’. Two mutants were isolated and tested. Mutant d1 contains 
a 1 bp deletion (nucleotide 127 of the open reading frame: 5’-G-3’), which results in a 
change in reading frame after amino acid 41 and a premature stop codon after amino acid 
42 compared to 107 amino acids for the WT protein. Mutant d8 contains an 8 bp deletion 
(nucleotides 124-131 of the open reading frame: 5’- TGTGGATC -3’), which results in a 
change in reading frame after amino acid 41 and a premature stop codon after amino acid 
87 compared to 107 amino acids for the WT protein. The predicted mutant protein lacks 
key functional domains including 6 out 10 cysteine residue and is likely non-functional 
(Bullock et al., 2004). This assertion is supported by the observation that a mutant form 
of prok2 identified in humans with Kallmann syndrome that was shown to be inactive in 
vitro was truncated at amino acid 54 (Pitteloud et al., 2007).  The two zebrafish prok2 
mutants exhibited similar phenotypes and mutant d8 was used for all reported 
experiments. prok2 mutants were genotyped using the primers 
5’CAAGTGGACACACCGAACAC-3’ and 5’-ATCCTGGAATGGAAATGGTG-3’. 
PCR products were then digested with BamHI (R0136, NEB). Mutant (404 bp) and WT 
(155 bp + 257 bp) bands were distinguished by running the digested PCR product on a 2% 
agarose gel. 
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prokr1 mutant. TALEN target sites were 5’-TACTTGAGGACTGTGTC-3’ and 5’-
TGGCCAGCAGAGCATT-3’. Two mutants were isolated and tested. Mutant d7 contains 
a 7 bp deletion (nucleotides 411-422 of the open reading frame: 5’-TACGTGTCCAC-3’ 
was replaced by 5’-TTGGT3’), which results in a change in reading frame after amino 
acid 136 and a premature stop codon after amino acid 156 compared to 385 amino acids 
for the WT protein. Mutant d22 contains a 22 bp deletion (nucleotides 405-426 of the 
open reading frame: 5’- TCTCTCTACGTGTCCACCAATG-3’), which results in a 
change in reading frame after amino acid 134 and a premature stop codon after amino 
acid 151 compared to 385 amino acids for the WT protein. Both predicted mutant 
proteins lack more than 3 transmembrane domains from the C terminus and are therefore 
likely non-functional (Lin et al., 2002). The mutants exhibited similar phenotypes and 
mutant d7 was used for all reported experiments. prokr1 mutants were genotyped using 
the primers 5’-GGCGTTGGTAATTGCGTATT-3’ and 5’-
TATCAGCCACCAGCACTCTG-3’. PCR products were then digested with AflIII 
(R0541, NEB). Mutant (527 bp) and WT (218 bp + 316 bp) bands were distinguished by 
running the digested PCR reaction on a 2% agarose gel. 
 
prokr2 mutant. TALEN target sites were 5’-TCTCACAGAAACAGCCAT-3’ and 5’-
TACAGCTGCCACGTGGCT-3’. Two mutants were isolated and tested. Mutant d1 
contains a 1 bp deletion (nucleotide 12 of the open reading frame: 5’- C-3’), which results 
in a change in reading frame after amino acid 4 and a premature stop codon after amino 
acid 13 compared to 396 amino acids for the WT protein. Mutant d14 contains a 14 bp 
deletion (nucleotides 7-20 of the open reading frame: 5’- GACGCCAATATCAG -3’), 
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which results in a change in reading frame after amino acid 2 and a premature stop codon 
after amino acid 21 compared to 396 amino acids for the WT protein. The predicted 
mutant protein lacks all 7 transmembrane domains and is likely non-functional (Lin et al., 
2002). The mutants exhibited similar phenotypes and mutant d1 was used for all reported 
experiments. prokr2 mutants were genotyped using the primers 5’-
TGAGCGTAATGCTAATGGTCT-3’ and 5’-CCAGAGTGGCGATAAACACA-3’. PCR 
products were then digested with BsaHI (R0556, NEB). Mutant (428 bp) and WT (190 bp 
+ 239 bp) bands were distinguished by running the digested PCR reaction on a 2% 
agarose gel.  
 
The ET(vmat2:EGFP) line has previously been described (Wen et al., 2008).  
 
Behavioral experiments. Videotracker experiments were performed as previously 
described (Prober et al., 2006; Rihel et al., 2010b; Gandhi et al., 2015)). Larval zebrafish 
were raised on a 14 hour:10 hour light:dark cycle at 28.5oC with lights on at 9 am and off 
at 11 pm, except for constant light and dark experiments where larvae were raised in 
constant light or dark conditions at 28.5oC. On the fourth day of development, individual 
larvae were placed in each wells of a 96-well plate (7710-1651, Whatman) containing 
650 μL of E3 embryo medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM 
MgSO4, pH 7.4). Plates were sealed with an optical adhesive film (4311971, Applied 
Biosystems) to prevent evaporation. Locomotor activity was monitored using an 
automated videotracking system (Viewpoint Life Sciences) with a Dinion one-third inch 
Monochrome camera (Dragonfly 2, Point Grey) fitted with a variable-focus megapixel 
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lens (M5018-MP, Computar) and infrared filter. The movement of each larva was 
recorded using the quantization mode. The 96-well plate and camera were housed inside 
a custom-modified Zebrabox (Viewpoint Life Sciences) that was continuously 
illuminated with infrared lights and with customizable white light. The 96-well plate was 
housed in a chamber filled with recirculating water to maintain a constant temperature of 
28.5°C. The parameters used for detection were: detection threshold, 15; burst, 29; freeze, 
3; bin size, 60 seconds. Heat shocks were performed by removing the 96-well plate from 
the videotracker and placing it in a 37oC water bath for 1 hour. At the end of each 
experiment, each well was examined and those containing bubbles (introduced during the 
sealing process) or more or less than a single larva were excluded from analysis. 
Videotracker sleep/wake data was processed using custom PERL and Matlab (version 
R2013a, The Mathworks, Inc) scripts. Any one minute period with less than 0.1 second 
of total movement was defined as one minute of sleep (Prober et al., 2006). A sleep bout 
was defined as a continuous string of sleep minutes. Average activity was defined as the 
average amount of detected activity in seconds/hour, including all rest bouts. Statistical 
tests were performed using Prism 6 (GraphPad).  
 
in situ hybridization (ISH) and immunohistochemistry. Samples were fixed in 4% 
paraformaldehyde for 16 hours at room temperature. ISH was performed using 
digoxigenin (DIG)-labeled antisense riboprobes (Thisse and Thisse, 2008). Antisense 
prok2 riboprobe for was generated from a zebrafish EST (Genbank EB931495; Open 
Biosystems, Inc.). Antisense prokr1 riboprobe was generated using a PCR fragment as 
template. The fragment was amplified using primers 5’-
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TGACTCGCAGTCACACAGTTC-3’ and T7 promoter-coupled 5’-
GAATTGTAATACGACTCACTATAGGGTCTTCCAAAGTATGGGTCGAA-3’. 
Antisense prokr2 riboprobe was generated using a PCR fragment as template. The 
fragment was amplified using primers 5’-GCACAGAGAATGAGCGTCTG-3’ and T7 
promoter-coupled 5’-
GAATTGTAATACGACTCACTATAGGGTCACTGAGGCTGAGGGTATAAA-3’. 
Images were acquired using a Zeiss Axio ImagerM1 microscope. Fluorescent ISH used 
DIG-, 2, 4-dinitrophenol (DNP)- and fluorescein-labeled antisense riboprobes with the 
TSA Plus DNP System (PerkinElmer). For immunohistochemistry, rabbit polyclonal 
anti-GFP (1:1000; MBL International, #598) and Alexa Fluor 568 goat anti-rabbit (1:500; 
Invitrogen, #A-11011) antibodies were used. 4’,6-Diamidino-2-phenylindole 
dihydrochloride (DAPI) (268298, EMD Millipore) staining was performed in 1:5000 in 2% 
DMSO/PBS + 0.25% triton X-100 for at least 4 hours at room temperature. Samples were 
mounted in 50% glycerol/PBS, and imaged with a Zeiss LSM 780 laser-scanning 
confocal microscope with 405 nm, 488 nm, and 561 nm lasers and 40x objective. Images 
were processed using Fiji (Schindelin et al., 2012). 
 
Quantitative reverse transcription-PCR. Larval zebrafish were raised on a 14 hour:10 
hour light:dark cycle at 28.5oC with lights on from 9 am to 11 pm. Total RNA was 
isolated using RNeasy (74106, Qiagen) from 25 pooled larvae at 11am, 4 pm, 9 pm, 1 am, 
4 am, and 8 am at 6 dpf , and at 11 am at 7 dpf. cDNA was synthesized from 5 μg of total 
RNA using Superscript III Reverse Transcriptase (18080-051, Invitrogen) and 
quantitative PCR was carried out using SYBR green master mix (4364346, Life 
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Technologies) in triplicate on an ABI PRISM 7900HF (Life Technologies) instrument. 
ΔCt was calculated using actin as a reference gene. Relative expression levels were 
calculated using the 2-ΔΔCt method by normalizing to the sample with the highest ΔCt 
value for each gene (Schmittgen and Livak, 2008). Primers for amplification: prok2, 5’-
GGGGCATGTGAGAAGGACTCT-3’ and 5’-TCTTCTCCCTCCTGACCCATT-3’; 
per3, 5’-CTCCAGCTTTCACAGCACTCA-3’ and 5’-
ACGCTTCTTCATCTCCTGCAC-3’; actin, 5’-TCCTCCCTGGAGAAGAGCTATG-3’ 
and 5’-TCCATACCCAGGAAGGAAGG-3’. 
 
prok2 fluorescent in situ hybridization. Larvae were raised in on a 14 hour:10 hour 
light:dark cycle at 28.5C with lights on from 9 am to 11 pm until 6 dpf. Samples were 
fixed in 4% PFA overnight at room temperature and fluorescent in situ hybridization was 
performed on dissected brains using a DIG-labeled antisense riboprobe specific for prok2 
and the TSA Plus System (NEL741001, PerkinElmer). Samples were developed using 
Cy3 amplification reagent at 1:200 for 10 minutes. Imaging was performed using Zeiss 
780 confocal microscope using the same settings for all samples (40x objective). Total 
integrated pixel density was measured by subtracting background integrated pixel density 
from total integrated pixel intensity using ImageJ.  
  
 
  57 
Supplemental figures and table 
 
 
 
Figure S2.1. prok2 expression does not oscillate in circadian manner in larval 
zebrafish. (A) qRT-PCR analysis of prok2 and per3 mRNA are shown. prok2 expression 
does not change significantly over 24 hours, while per3 expression oscillates with a 24 
hour period, compared with actin. Larvae were raised in 14:10 hr light:dark conditions 
and collected at the indicated times beginning at 2 am (ZT 2) at 6 dpf. Triplicate 
biological samples were collected at each time point.  Mean ± SEM values are shown 
(***p < 0.001 by one-way ANOVA) followed by Tukey’s test). (B) Representative 
images of prok2 FISH in larval zebrafish brains fixed at the indicated time. prok2 mRNA 
levels appear to be similar at all circadian time points. Scale bar: 10 μm. (C) 
Quantification of total prok2 fluorescence pixel intensity is shown. prok2 expression does 
not oscillate (peak:trough ratio=1.24, p=0.40 by one-way ANOVA). Mean±  SEM is 
shown. Five brains were quantified for each time point. 
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Figure S2.2. The Prok2 overexpression phenotype depends on lighting condition and 
not on circadian rhythms. (A-F) Following heat shock at 5 dpf (grey bar), larvae raised 
in normal light dark cycle and tested in constant light are less active for at least 2 days (A, 
C) and sleep more for up to 16 hours (B, D). (G-L) Following heat shock at 5 dpf (grey 
bar), larvae raised and tested in constant dark are more active and sleep less for at least 2 
days. Data from one representative experiment (A, B, G, H) and two experiments 
combined (C-F, I-L) are shown. Bar graphs show mean ± SEM. n indicates number of 
larvae analyzed. *p < 0.05, ***p < 0.001 by two-tailed Student’s t test. Note that (I, K) 
exclude the first two hours after heat shock to allow larvae to recover from the heat shock. 
*p < 0.05, **p<0.01, ***p < 0.001 by two-tailed Student’s t test.  
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Figure S2.3. prok2 and prok receptor mutants do not show apparent development 
defects. (A) Images of representative WT, prok2-/-, and prokr1-/-; prokr2-/- adult 
zebrafish are shown. All fish are similar in size and morphology. (B) Representative 
images of ISH using probes specific for gonadotropin-releasing hormone 2 (gnrh2), 
gnrh3, tyrosine hydroxylase 1 (th1) and empty spiracles homeobox 1 (emx1) in WT, 
prok2-/-, and prokr1-/-; prokr2-/- larvae are shown. Dashed boxes indicate olfactory 
region. Larvae of all genotypes show similar expression levels and patterns of each gene. 
Scale bars: (A) 5 mm. (B) 100 μm.  
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Figure S2.4. prok2 receptor mutants lack sleep/wake phenotypes. (A, B) Amino acid 
sequence alignments of human (Hs), mouse (Mm), and zebrafish (Dr) Prokr1 (A) and 
Prokr2 (B) orthologues, and the sequences of two zebrafish Prokr1 mutant proteins (d7 
and d22) and two zebrafish Prokr2 mutant proteins (d1 and d14) that were generated in 
this study are shown. Prokr1 mutant proteins are truncated at the 4th transmembrane 
domain. Prokr2 mutant proteins are truncated before the 1st transmembrane domain. (C-H) 
prokr1-/-, prokr1+/-, and prokr1+/+ larvae showed similar amounts of locomotor activity 
(C, E, F) and sleep (D, G, H) during the day and night. (I-N) prokr2-/-, prokr2+/-, and 
prokr2+/+ larvae showed similar amounts of locomotor activity (I, K, L) and sleep (J, M, 
N) during the day and night. (O-T) prokr1+/-; prokr2+/-, prokr1-/-; prokr2+/-, 
prokr1+/-; prokr2-/-, and prokr1-/-; prokr2-/- larvae showed similar amounts of 
locomotor activity (O, Q, R) and sleep (P, S, T) during the day and night. Data from one 
experiment is shown for Prokr1 mutant. Data from two experiments are shown for Prokr2 
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mutant and Prok double receptor mutants. Bar graphs show mean ± SEM. n indicates 
number of larvae analyzed. *p < 0.05, **p < 0.01 and ***p < 0.001 by one-way ANOVA 
and Dunnett’s test using comparison to WT.  
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Figure S2.5. Prok2 overexpression phenotype does not require Prokr1. Following 
heat shock (grey bar in A, B), Prok2 overexpression-induced locomotor activity (A, C, D) 
and sleep (B, E, F) phenotypes were similar in prokr1-/- (yellow) and prokr1+/- larvae 
(red). Data from two experiments are shown. Bar graphs show mean ± SEM. n indicates 
number of larvae analyzed. **p < 0.01, ***p < 0.001 by two-way ANOVA and Tukey’s 
multiple comparison test. 
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Figure S2.6. Prok2 overexpression phenotype persists in dbh mutant larvae. Prok2 
was overexpressed in either dbh+/- or dbh -/- larvae on 5 dpf (grey bar). Larvae in dbh-/- 
background exhibited significantly reduced activity (A, C, D) and increased sleep (B, E, 
F) than those in dbh+/- background both during the day and night as well as before and 
after heat shock. Prok2 overexpression phenotype persisted in both dbh+/- and dbh-/- 
larvae, decreasing activity and increasing sleep during the day, but increasing activity and 
decreasing sleep at night. Note the lack of difference between Tg(hsp:Prok2); dbh+/- and 
Tg(hsp:Prok2); dbh-/- larvae on day 5 post heat shock is likely due to a floor effect. The 
magnitude of difference between Tg(hsp:Prok2); dbh+/- and Tg(hsp:Prok2); dbh-/- 
larvae on day 6 is similar to that between dbh+/- and dbh-/- larvae. Data from two 
experiments are shown. Bar graphs show mean ± SEM. n indicates number of larvae 
analyzed.  (*p < 0.05, **p < 0.01, ***p < 0.001 by two-way ANOVA and Tukey’s 
multiple comparison test).  
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Mutants/Drugs Affected Pathway 
dopamine beta hydroxylase mutant norepinephrine 
histidine decarboxylase mutant histamine 
tryptophan hydroxylase 2 mutant serotonin 
arylalkylamine N-acetyltransferase-2 mutant melatonin 
melatoninm 10 μM  melatonin 
dopamine receptor 1 antagonist drug, SCH 23390, 5 μM dopamine 
hypocretin receptor mutant hypocretin 
glucocorticoid receptor mutant cortisol and glucocorticoids 
 
 
Table S2.1. List of mutants and small molecules tested for effects on Prok2 
overexpression phenotypes.  
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CHAPTER 3 
 
NEURONAL ACTIVATION AND ABLATION IN FREELY BEHAVING 
ZEBRAFISH USING TRP CHANNELS  
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3.1 Abstract 
 
The zebrafish has recently emerged as a useful model system to study neural circuits 
and behavior, but tools to modulate the activity of genetically specified neurons in freely 
behaving animals are limited. As a poikilotherm that lives in water, zebrafish are 
particularly amenable to thermal and pharmacological perturbations. Here we exploit 
these properties by using transient receptor potential (TRP) channels to inducibly activate 
and ablate specific neuronal populations in zebrafish larvae using the appropriate 
chemical and thermal agonists for heterologously expressed TRPV1, TRPM8, and 
TRPA1. The small size of zebrafish larvae, and the ability to modulate TRP channel 
function by changing the water temperature or adding the appropriate small molecule to 
the water, allows for high-throughput behavioral experiments in 96-well plates. We found 
that expression of TRP channels in Rohon-Beard sensory neurons enables agonist-
dependent neuronal activation and startle-like behavioral responses. TRPV1-expressing 
neurons can be ablated with high concentration of its agonist. Our results show that TRP 
channels complement existing reagents and expand the scope of behavioral experiments 
that can be performed using zebrafish. 
 
3.2 Introduction 
 
The complexity of mammalian neural circuits and the difficulty of manipulating 
them present major challenges in deciphering neural mechanisms that regulate behavior. 
To overcome these challenges, the zebrafish has recently been developed as a model 
system to characterize neuronal mechanisms that regulate behavior due to several 
advantageous features. First, zebrafish embryos and larvae are transparent, which allows 
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observation and manipulation of neurons in live animals (Arrenberg and Driever, 2013; 
Friedrich et al., 2013; Leung et al., 2013). Second, morphological and molecular analyses 
have shown that zebrafish and mammalian brains are similar (Schweitzer et al., 2012; 
Chiu and Prober, 2013), so neuronal circuits that regulate zebrafish behaviors are likely 
to be conserved in mammals. For example, the wake-promoting hypocretin system has 
been shown to be molecularly, anatomically, and functionally conserved in zebrafish 
(Kaslin et al., 2004; Faraco et al., 2006; Prober et al., 2006; Yokogawa et al., 2007; Elbaz 
et al., 2012). Third, by the fifth day of development, zebrafish larvae are free-living and 
exhibit complex behaviors, including hunting and escape responses, allowing detailed 
behavioral analyses (Orger et al., 2008; Bianco et al., 2011; Patterson et al., 2013; Trivedi 
and Bollmann, 2013). Fourth, the ability to rapidly raise thousands of zebrafish allows for 
large-scale screens for genes and neurons that affect behavior (Muto et al., 2005; Wyart 
et al., 2009). Fifth, zebrafish behaviors can be studied using small molecules that are 
taken up through the gills or absorbed through the skin (Kokel et al., 2010; Rihel et al., 
2010a; Wolman et al., 2011), and zebrafish larvae lack a mature blood brain barrier 
(Fleming et al., 2013), thus allowing small molecule access to the brain. The zebrafish 
therefore provides a useful system to characterize neuronal mechanisms that regulate 
behavior. 
A limitation to using zebrafish for these studies is a paucity of tools to manipulate 
neuronal activity. Several transgenic tools have been developed that allow genetically 
specified neurons to be stimulated or inhibited. For example, optogenetic tools stimulate 
or inhibit neurons when illuminated by specific wavelengths of light (Mattis et al., 2011). 
In principle, the transparency of zebrafish larvae makes them well suited for this 
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technology. Indeed, optogenetic tools have been used to characterize the roles of specific 
neurons in sensory and motor control in restrained zebrafish larvae (Douglass et al., 2008; 
Arrenberg et al., 2009; Wyart et al., 2009). However, the light stimulus elicits a strong 
behavioral response in unrestrained larvae (Zhu et al., 2009), which is problematic for 
many behavioral assays, including those used to study sleep (Prober et al., 2006). The 
confounding effects of light are avoided by tools that modulate neuronal activity in the 
presence of specific small molecules (Szobota et al., 2007; Arenkiel et al., 2008; 
Alexander et al., 2009; Magnus et al., 2011) or at specific temperatures (Hamada et al., 
2008), but these technologies have not been tested in zebrafish. Here we describe the use 
of heterologous transient receptor potential (TRP) channels that allow activation or 
ablation of genetically specified neurons in freely behaving zebrafish larvae. 
In this study, we set out to develop tools that could be used to activate genetically-
specified neurons in freely behaving zebrafish larvae. We chose to test three 
transmembrane channels from the TRP cation channel family that are activated by 
specific small molecules or at specific temperatures in some species, and have been used 
to stimulate neural activity in mammals (Arenkiel et al., 2008), Drosophila (Marella et 
al., 2006; Hamada et al., 2008) and C. elegans (Tobin et al., 2002). We tested the rat 
TRPV1 channel, which is activated by the small molecule capsaicin (Csn) (Caterina et 
al., 1997), the rat TRPM8 receptor, which is activated by the small molecule menthol, 
and the Crotalus atrox (rattlesnake) TRPA1 receptor, which is activated at temperatures 
above 28oC (Gracheva et al., 2010). Importantly, the zebrafish TRPV1 ortholog contains 
a mutation that renders it insensitive to Csn (Jordt and Julius, 2002; Gau et al., 2013), the 
zebrafish genome lacks a TRPM8 ortholog, and the two zebrafish TRPA1 paralogs are 
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not thermosensitive (Prober et al., 2008). Because wild-type zebrafish in principle should 
not respond to agonists for these heterologous TRP channels, and bath application of 
small molecules and changes in water temperature can be applied to high-throughput 
assays of freely behaving zebrafish larvae, these channels could provide a simple yet 
powerful approach to activate genetically specified neurons without the confounding 
effects of light on behavior. 
 
3.3 Expression of heterologous TRP channels in zebrafish sensory neurons induces 
agonist-dependent behavioral phenotypes 
To test whether TRP channels can be used to activate genetically specified 
zebrafish neurons, we used the islet-1 sensory neuron enhancer (Higashijima et al., 2000) 
to express rat TRPV1, rattlesnake TRPA1, and rat TRPM8 and in zebrafish trigeminal 
and Rohon-Beard sensory neurons (Figures 3.1A-3.1C, 3.2A-2C, 3.3A-3.3C), and 
assayed for behavioral responses to the appropriate channel agonist. 
As has previously been shown (Gau et al., 2013), we found that wild-type 
zebrafish embryos did not exhibit a behavioral response to Csn (Figure 3.1G, S3.1). 
Similarly, 24 hpf transgenic zebrafish embryos that expressed TRPV1 in sensory neurons 
exhibited little locomotor activity when treated with DMSO vehicle control or 0.1 μM 
Csn (Figures 3.1D-3.1I). However, exposure to 0.3 μM Csn or higher concentrations 
induced robust locomotor activity in transgenic embryos (Figures 3.1D-3.1I), consistent 
with activation of sensory neurons and similar to the phenotype observed upon activation 
of sensory neurons using channelrhodopsin-2 (ChR2) (Douglass et al., 2008). At 1 μM, 
Csn induced a behavioral response in 100% of embryos (Figure 3.1D), with an average 3 
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second response latency (Figure 3.1F), consisting of very intense locomotor activity 
lasting for 45 seconds (Figure 3.1E) and less intense activity lasting for up to 2 hours 
(Figures 3.1G-3.1I). These results suggest that Csn can activate TRPV1-expressing 
neurons, and thus affect behavior, over long periods of time. Following a 3 or 5 minute 
washout period in E3 medium, reapplication of Csn elicited a similar behavioral response 
in 60% and 95% of embryos, respectively (data not shown). 
To test the ability of rattlesnake TRPA1 to activate zebrafish neurons, we raised 
embryos expressing the channel in sensory neurons at temperatures below 28oC, because 
the channel is activated at and above 28oC (Gracheva et al., 2010). We found that slowly 
raising the water temperature from 22.5oC to 28.5oC failed to produce a robust behavioral 
response (data not shown). In contrast, abruptly raising the temperature from 22.5oC to 
25.5oC induced a behavioral response in 100% of embryos (Figure 3.2D, S3.2), with an 
average 1.5 second response latency (Figure 3.2F), consisting of intense locomotor 
activity lasting for 14 seconds (Figure 3.2E) and less intense activity lasting for up to 2 
hours (Figures 3.2G-3.2I). Increasing the temperature from 25oC to 28oC produced 
similar results (data not shown). In contrast, temperature increases up to 30oC failed to 
elicit behavioral responses in non-transgenic sibling embryos (Figure S3.3 and data not 
shown), consistent with previous observations (Prober et al., 2008). The TRPA1-
dependent phenotype was remarkably sensitive to temperature, as an increase of as little 
as 1oC produced a significant behavioral response (Figures 3.2D-3.2F). Similar to 
TRPV1, the TRPA1-dependent behavioral response could be induced again in 95% of 
TRPA1-expressing embryos after returning them to 22oC for as little as 2 minutes (data 
not shown). 
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Figure 3.1. Csn induces locomotor activity in embryos expressing TRPV1 in sensory 
neurons. A 24 hpf Tg(islet1:GAL4VP16, 4xUAS-TRPV1-RFPT) embryo exhibits RFPT 
fluorescence in trigeminal (arrowhead) and Rohon-Beard sensory neurons (A), as 
confirmed by trpv1-rfpt (red) and islet1 (green) double fluorescent ISH (B). The boxed 
region in (B) is shown at higher magnification in (C). Arrows indicate Rohon-Beard 
neurons that express both trpv1-rfpt and islet1. Scale bars indicate 100 μm (A, B) and 25 
μm (C). (D-F) At 24 hpf, transgenic embryos exhibited a dose-dependent behavioral 
response to Csn, responding to as little as 0.3 μM Csn (D), with a phase of robust 
bursting movements lasting up to 45 seconds (E) and with a short response latency (F). n 
indicates number of embryos tested. Non-transgenic siblings did not respond to Csn at 
any of the concentrations tested (see Figure S3.1 and panel G). (G-I) At 2 dpf, transgenic 
embryos (bold colors), but not their non-transgenic siblings (faint colors), exhibited a 
significant increase in locomotor activity (G, H) and in the number of movement bouts (I) 
in response to 1-10 μM Csn that lasted for up to 2 hours. Mean (G) and mean +/- S.E.M. 
(E, F, H, I) are shown. ** indicates p<0.01 for transgenic embryos compared to their 
identically treated non-transgenic siblings using the Kruskal-Wallis test and the Steel-
Dwass test to correct for multiple comparisons. 20 embryos were tested for each 
condition (G-I). 
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Figure 3.2. Increased temperatures induce locomotor activity in embryos expressing 
TRPA1 in sensory neurons. A 24 hpf Tg(islet1:GAL4VP16, 4xUAS-TRPA1-RFPT) 
embryo exhibits RFPT fluorescence in trigeminal (arrowhead) and Rohon-Beard sensory 
neurons (A), as confirmed by trpa1-rfpt (red) and islet1 (green) double fluorescent ISH 
(B). The boxed region in (B) is shown at higher magnification in (C). Arrows indicate 
Rohon-Beard neurons that express both trpa1-rfpt and islet1. This transgenic line also 
expresses trpa1-rfpt in some spinal cord interneurons. Scale bars indicate 100 μm (A, B) 
and 25 μm (C). (D-F) Embryos were raised at 26.5oC and tested at 30 hpf, at which time 
they were at a similar developmental stage as 24 hpf embryos raised at 28.5oC. 
Locomotor activity was induced when the temperature was rapidly increased by 1oC to 
5oC (D), with a phase of robust bursting movements lasting up to 15 seconds (E) and with 
a short response latency (F). n indicates number of embryos tested. Wild-type embryos 
did not exhibit behavioral responses to any of these temperature changes (Figure S3.2 and 
data not shown). (G-I) At 2 dpf, transgenic embryos (red), but not their non-transgenic 
siblings (blue), exhibited significant increases in locomotor activity (G, H) and in the 
number of movement bouts (I) following a change in the water temperature from 25.5oC 
to 28.5oC that lasted for up to 2 hours. The change in water temperature is indicated by an 
arrow in (G). Mean (G) and mean +/- S.E.M. (E, F, H, I) are shown. * indicates p<0.05 
and ** indicates p<0.01 for transgenic embryos compared to their identically treated non-
transgenic siblings using the Wilcoxon rank-sum test. n indicates the number of embryos 
analyzed. 
 
 
We also observed robust behavioral responses following application of menthol to 
embryos expressing rat TRPM8 in sensory neurons (Figures 3.3D-3.3F, S3.3), although 
higher agonist levels were required compared to TRPV1. For example, application of 100 
μM menthol induced a behavioral response in 90% of embryos (Figure 3.3D), with an 
average 5 second response latency (Figure 3.3F), consisting of intense locomotor activity 
that lasted for 6 seconds (Figure 3.3E). In contrast, non-transgenic sibling embryos failed 
to respond to menthol at concentrations up to 1 mM (Figure S3.3 and data not shown). 
Similar to TRPV1 and TRPA1, the TRPM8-dependent behavioral response to menthol 
could be repeatedly induced in 90% of embryos following a 2 minute drug washout phase 
(data not shown). Taken together, our results suggest that TRPV1, TRPA1, and TRPM8 
can each be used to activate genetically specified neurons, and thus affect behavior, when 
stimulated by its specific agonist. 
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Figure 3.3. Menthol induces locomotor activity in embryos expressing TRPM8 in 
sensory neurons. A representative 24 hpf wild-type embryo injected with the 
Tg(islet1:GAL4VP16, 4xUAS-TRPM8-RFPT) transgene exhibits TRPM8-RFPT 
fluorescence in a subset of sensory neurons (A), as confirmed by trpm8-rfpt (red) and 
islet1 (green) double fluorescent ISH (B). The boxed region in (B) is shown at higher 
magnification in (C). Arrows indicate Rohon-Beard neurons that express both trpm8-rfpt 
and islet1. Scale bars indicate 100 μm (A, B) and 25 μm (C). (D-F) At 24 hpf, transgenic 
embryos exhibited a dose-dependent behavioral response to menthol, responding to as 
little as 30 μM menthol (D), with a phase of robust bursting movements lasting up to 9 
seconds (E) and with a short response latency (F). Wild-type embryos did not respond to 
menthol at any of the concentrations tested (Figure S3.3 and data not shown). Mean (D) 
and mean +/- S.E.M. (E, F) are shown. n indicates number of embryos tested. 
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3.4 Heterologous TRP channels activate zebrafish sensory neurons in a dose-
dependent manner 
To more directly test whether TRPV1-expressing sensory neurons are activated 
by Csn, we assayed neuronal activity in fixed animals using c-fos in situ hybridization 
(ISH) (Baraban et al., 2005) and in real-time using the genetically encoded calcium 
sensor GCaMP5 (Portugues et al., 2013) following bath application of Csn to intact 
zebrafish embryos. We observed a dose-dependent increase in the number of c-fos-
positive TRPV1-expressing sensory neurons, with 90% of these neurons expressing c-fos 
in embryos exposed to 1 μM Csn for 45 minutes (Figures 3.4B, 3.4D). In contrast, we 
observed no c-fos expression in non-transgenic siblings exposed to Csn (Figures 3.4B, 
3.4D) or in transgenic embryos exposed to vehicle control (Figures 3.4A, 3.4D). 
Consistent with these results, Csn induced a dose-dependent increase in GCaMP5 
fluorescence in TRPV1-expressing sensory neurons (Figures 3.4E-3.4J). For example, 
during 440 seconds of exposure to 1 μM Csn, 24% of TRPV1-expressing sensory 
neurons exhibited transient increases in GCaMP5 fluorescence (Figures 3.4F, 3.4J). At 3 
μM Csn, 62% of these neurons responded, with generally larger and longer increases in 
GCaMP5 fluorescence (Figures 3.4G, 3.4J). At 10 μM Csn, 82% of TRPV1-expressing 
sensory neurons exhibited very large increases in fluorescence that were sustained until 
Csn was washed out of the recording chamber (Figures 3.4H, 3.4J). No changes in 
GCaMP5 fluorescence were observed in transgenic embryos exposed to vehicle control 
(Figures 3.4E, 3.4J) or in non-transgenic siblings exposed to 10 μM Csn (Figures 3.4I, 
3.4J). The average amplitude of calcium transients increased as neurons were exposed to 
higher Csn concentration (Figures 3.4L). The fractional change in GCaMP response 
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showed a trend of increase in higher Csn concentration (Figure 3.4M).  The average 
frequency of calcium transients does not show a dose-dependent increase (Figure 3.4K) 
because 81% of neurons activated by 10 μM Csn showed prolonged calcium transients 
(Figure 3.4N). These results indicate that TRPV1-expressing sensory neurons, but not 
wild-type sensory neurons, are activated by Csn in a dose-dependent manner. Our data 
also suggest that 10 μM Csn causes abnormally high and sustained cytoplasmic calcium 
levels in TRPV1-expressing neurons that may have deleterious effects. In addition, we 
observed that 1 μM Csn can repeatedly activate same neurons (Figures 3.5A, 3.5B). 77% 
of neurons responded to the first Csn application also responded to second Csn 
application with similar average frequency and amplitude of calcium transients and 
fractional change in GCaMP response (Figures 3.5C-3.5E). Note there are sometimes 
additional neurons respond to second Csn application that did not respond to first Csn 
application.  
We next tested whether Rohon-Beard sensory neurons expressing TRPA1 or 
TRPM8 can be activated by their respective agonists using c-fos ISH. We found that 44% 
of TRPA1-expressing sensory neurons expressed c-fos following a temperature shift from 
25oC to 28oC (Figures 3.6B, 3.6D), while no c-fos expression was observed in identically 
treated non-transgenic siblings (Figures 3.6C, 3.6D). We observed c-fos expression in 
only 3% of TRPA1-expressing sensory neurons in embryos maintained at 25oC (Figures 
3.6A, 3.6D). Similarly, 65% of TRPM8-expressing sensory neurons expressed c-fos 
following exposure to 100 μM menthol (Figures 3.6F, 3.6H), while no c-fos expression 
was observed in TRPM8-expressing sensory neurons exposed to vehicle control (Figures 
3.6E, 3.6H) or in non-TRPM8-expressing sensory neurons exposed to 100 μM menthol 
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(Figures 3.6G, 3.6H). We conclude that TRPA1- and TRPM8-expressing sensory 
neurons, but not wild-type sensory neurons, are activated by increased temperature and 
menthol, respectively. 
 
 
 
Figure 3.4. Csn activates TRPV1-expressing Rohon-Beard neurons. (A-C) 
Representative double fluorescent ISH images showing that c-fos expression is induced 
in trpv1-rfpt-expressing Rohon-Beard neurons in transgenic embryos exposed to 1 μM 
Csn for 45 minutes (B), but not in transgenic siblings exposed to the vehicle control (A) 
or non-transgenic siblings exposed to 10 μM Csn (C). islet1 expression was used to 
identify Rohon-Beard neurons in non-transgenic embryos in (C). Arrows and arrowheads 
indicate Rohon-Beard sensory neurons that do and do not express c-fos, respectively. (D) 
Quantification of the percentage of trpv1-rfpt-expressing Rohon-Beard neurons that 
express c-fos following the indicated treatments. (E-I) Representative images showing 
TRPV1-RFPT expressing neurons (E-H) and GCaMP5 fluorescence before (E’-I’) and 
after (E”-I”) addition of Csn at the indicated concentrations. Rohon-Beard neurons were 
identified in non-transgenic controls based on their morphology and location using basal 
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GCaMP5 fluorescence (I). White arrows indicate Rohon-Beard neurons whose 
fluorescence intensities are quantified in panels (E”’-I”’). Time of Csn addition is 
indicated by black arrows (E”’-I”’). (J) Quantification of the percentage of trpv1-rfpt-
expressing Rohon-Beard neurons that show increased GCaMP5 fluorescence following 
exposure to Csn at the indicated concentrations. n indicates number of neurons analyzed. 
(K-N) Quantification of average calcium transients/min, average amplitude of calcium 
transients, fractional change in GCaMP response, and % of cells show prolonged calcium 
response of the cells that showed at least one calcium transient (defined as at least 50% 
increase in ΔF/F0). Note that average calcium transients for 10 μM are lower because 
most neurons show prolonged calcium response. Scale bars=25 μm. 3 animals were used 
were used for each condition in (D) and (J). Animals used: (D) n=4 for vehicle, n=6 for 
TRPV1+ in 1 μM Csn, n=7 for TRPV1+ in 3 μM Csn, n=7 for TRPV1+ in 10 μM Csn; (J) 
n=3 for each condition.  
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Figure 3.5. Csn can repeatedly induce GCaMP response in TRPV1+ neurons. (A) 
Representative images showing TRPV1-RFPT expressing neurons and GCaMP5 
fluorescence before addition of Csn. (B) Change in fluorescence (ΔF/F0) was plotted for 
every cells in the field of view for both first (1-12) and second round (1‘-12’) of Csn 
application in (A). (C-E) Quantification of average calcium transients/min, average 
amplitude of calcium transients, and fractional change in GCaMP response of 10 neurons 
that responded to both application of Csn. 3 animals were used for (C)-(E). Total number 
of cells that responded both times = 10. Scale bar = 50 μm.  
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Figure 3.6. Increased temperature activates TRPA1-expressing Rohon-Beard 
sensory neurons and menthol activates TRPM8-expressing Rohon-Beard neurons. 
(A-C) Representative images showing that c-fos expression is induced in trpa1-rfpt-
expressing Rohon-Beard neurons in transgenic embryos by 45 minutes after a change in 
water temperature from 25oC to 28oC (B), but not in non-transgenic siblings subjected to 
the temperature change (C) or in transgenic siblings maintained at 25oC (A). (D) 
Quantification of the percentage of trpa1-rfpt-expressing Rohon-Beard neurons that 
express c-fos following a 25oC to 28oC temperature change. (E-G) Representative images 
showing that c-fos expression is induced in trpm8-rfpt-expressing Rohon-Beard neurons 
in transgenic embryos exposed to 100 μM menthol for 45 minutes (F), but not in 
transgenic siblings exposed to the vehicle control (E) or non-transgenic siblings exposed 
to 100 μM menthol (G). (H) Quantification of the percentage of trpm8-rfpt-expressing 
Rohon-Beard neurons that express c-fos following exposure to 100 μM menthol. islet1 
expression was used to identify Rohon-Beard neurons in non-transgenic embryos (C, G). 
Arrows and arrowheads indicate Rohon-Beard sensory neurons that do and do not 
express c-fos, respectively. n indicates number of neurons analyzed. Scale bars=25 μm. 
Animals used: (D) n=3 for each condition; (H) n=4 for vehicle, n=8 for TRPM8+ in 100 
μM menthol, n=3 for TRPM8- in 100 μM menthol. 
 
 
 
3.5 Prolonged exposure to high Csn levels causes TRPV1-dependent cell death 
 
In addition to short-term behavioral experiments, we also tested the effect of 
activating each TRP channel over prolonged periods of time. By measuring TRPV1-
RFPT fluorescence as a proxy for cell number, we found that treating embryos containing 
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TRPV1-expressing sensory neurons with 1 μM Csn for up to 24 hours had no effect on 
the number of TRPV1-expressing neurons compared to controls (Figures 3.7A, 3.7B, 
3.7D). In contrast, the number of TRPV1-expressing neurons was dramatically reduced 
by treatment with 10 μM Csn for 10 hours, and virtually all TRPV1-expressing neurons 
were absent after 24 hours of exposure (Figures 3.7C, 3.7D). As a negative control, we 
used Et(e1b:GAL4VP16)s1102t; Tg(14xUAS-EGFP-Aequorin) double transgenic 
embryos to express EGFP, but not TRPV1, in Rohon-Beard sensory neurons. The 
number of these neurons was unaffected by exposure to 10 μM Csn for 24 hours (Figures 
3.7E-3.7G), indicating that Csn-mediated cell ablation requires TRPV1-expression. 
Importantly, embryos exposed to 10 μM Csn for up to 48 hours developed normally, 
appeared healthy and exhibited normal patterns and levels of locomotor activity. To 
confirm that the disappearance of RFPT fluorescence is a result of cell death and not 
suppression in transgene expression, we performed acridine orange staining, a vital dye 
that is often used as a marker for apoptosis in larval zebrafish (Tucker and Lardelli, 2007; 
Eimon, 2014). We observed acridine orange staining only in TRPV1+ neurons treated 
with 10 μM Csn (Figure 3.8).  In contrast to TRPV1, the number of TRPA1-expressing 
sensory neurons was not reduced in embryos incubated for 24 hours at 28oC compared to 
embryos maintained at 25oC (data not shown). Similarly, exposure to 100 μM menthol 
for up to 24 hours had no effect on the survival of TRPM8-expressing sensory neurons 
(data not shown). Based on these observations, we conclude that strong and prolonged 
activation of TRPV1 results in cell death, thus providing a novel and robust method for 
genetically targeted and inducible neuronal ablation in zebrafish. 
 
  83 
 
 
Figure 3.7. High Csn levels ablate TRPV1-expressing Rohon-Beard neurons. (A-C) 
Representative images of Tg(islet1:GAL4VP16, 4xUAS-TRPV1-RFPT) transgenic 
embryos incubated in vehicle control, 1 μM Csn or 10 μM Csn for the indicated time 
periods. RFPT fluorescence is dramatically reduced and essentially absent after 10 hr and 
24 hr, respectively, in 10 μM Csn, (C). Incubation in 1 μM Csn has no significant effect 
on RFPT fluorescence (B) compared to embryos treated with the vehicle control (A). (D) 
Quantification of RFPT fluorescence intensity for the conditions shown in (A-C). (E-F) 
Representative images of Et(e1b:GAL4VP16)s1102t; Tg(UAS-EGFP-Aequorin) double 
transgenic embryos incubated in vehicle control or 10 μM Csn for the indicated time 
periods. EGFP fluorescence is unaffected by Csn treatment. (G) Quantification of EGFP 
fluorescence intensity for the conditions shown in (E-F). The region of interest used to 
quantify fluorescence at each time point is indicated by the yellow boxes in (A) and (E). 
Mean +/- S.E.M. is shown in (D) and (G). ** indicates p<0.01 by Tukey’s HSD test. Six 
embryos were analyzed for each condition. Scale bars=100 μm. 
 
 
  84 
 
 
Figure 3.8. High Csn concentration induces cell death. Representative images showing 
acridine orange is observed only in TRPV1+ neurons treated with 10 µM Csn. No 
acridine orange signal is observed along the spinal cord in TRPV1- larvae. Scale bar = 50 
μm.  
 
 
3.6 Discussion 
 
In this study, we validate the use of TRP channels for specific activation and 
ablation of neurons in freely behaving zebrafish. This technology offers several 
advantages over currently available technologies. First, these pharmaco- and thermo-
genetic tools can be used in freely behaving zebrafish larvae without disruption of light-
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dependent behaviors such as sleep. While using small molecules and temperature change 
to activate TRP channels lacks the millisecond temporal resolution of optogenetic tools, 
fine scale neuronal activation may not be necessary for behaviors that are regulated over 
relatively long time scales, such as sleep/wake behaviors. Indeed, TRPA1 has become the 
method of choice for long-term activation of genetically specified neurons in Drosophila 
(Bernstein et al., 2012). While long-term activation of TRP channels may lead to 
desensitization and a cessation of neuronal activity, our experiments suggest that this can 
be rapidly reversed by washing out the small molecule or lowering the temperature, 
which is easy to perform in high-throughput behavior assays.  
Second, TRP channels can play a complementary role with existing genetic 
methods that report neuronal activity by release of light. For example, aequorin, a 
luminescent Ca2+ indicator, has recently been shown to report the activity of neurons in 
freely behaving zebrafish (Naumann et al., 2010). Additionally, TRP channels can be 
used in combination with fluorescent Ca2+ indicators such as GCaMP, whose use in 
combination with optogenetic tools such as ChR2 is complicated by the requirement of 
blue light to both activate ChR2 and excite GCaMP fluorescence.  
Third, the single channel conductance of TRP channels is 1000-fold larger than 
for ChR2 (Bernstein et al., 2012), so TRP channels can drive neuronal activity at lower 
expression levels, and weak promoters that do not achieve sufficiently high levels of 
ChR2 expression to stimulate neuronal activity may be sufficient for TRP channels. 
Lower expression also minimizes potential toxicity resulting from expression of a 
heterologous protein.  
Fourth, because the three TRP channels that we have described are activated by 
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distinct chemical or thermal agonists, they can be used to independently stimulate and/or 
ablate three distinct neuronal populations simultaneously. This feature will facilitate 
studies of how different neuronal populations interact to regulate behavior. 
Fifth, TRPV1-mediated cell ablation is faster, more robust and lacks the non-
specific toxicity associated with the standard approach used to ablate cells in zebrafish, in 
which a nitroreductase transgene converts the inert prodrug metronidazole into a cell-
autonomous toxin (Curado et al., 2007; Pisharath et al., 2007), although enhanced 
versions of nitroreductase have recently been described (Mathias et al., 2014; Tabor et 
al., 2014). As a result, TRPV1 will be particularly useful for neuronal populations that are 
not ablated by nitroreductase due to insufficiently strong transgene expression. 
Sixth, the ability of the TRPV1 to activate or ablate neurons depending on agonist 
concentration will allow for efficient screens for neurons that are necessary and/or 
sufficient for various behavioral phenotypes. More generally, it will be interesting to 
determine whether TRP channels can also be used to ablate and/or modulate calcium 
levels in non-neuronal cell types. 
Finally, we note that zebrafish are uniquely well-suited among standard vertebrate 
model organisms for using TRP channels to stimulate neuronal activity. Small molecules 
can be administered to zebrafish larvae by simply adding them to the water, where the 
compounds are rapidly taken up and can access neurons deep within the brain. 
Furthermore, the 28oC activation temperature of rattlesnake TRPA1 is within the normal 
temperature range of zebrafish larva, yet is high enough that zebrafish larvae can be 
raised and subjected to behavioral assays at slightly lower temperatures that do not 
activate the channel. In contrast, administering small molecules or heating neurons in the 
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mammalian brain is challenging, and all known TRP channels are either activated at 
temperatures below the 37oC body temperature of mammals or at higher temperatures 
that cause tissue damage (Bernstein et al., 2012). We therefore expect that TRP channels 
will be useful tools for studying zebrafish neuronal circuits and behavior. 
 
3.7 Materials and Methods 
 
Transgenic zebrafish. The rat TRPV1 channel (NM_031982) containing the E600K 
mutation, which increases sensitivity to capsaicin (Csn) by over 10-fold (Jordt et al., 
2000), the rat TRPM8 (NM_134371) channel, and the Crotalus atrox (rattlesnake) 
TRPA1 (GU562967) channel were each fused to TagRFPT (Shaner et al., 2008) at their 
C-termini. For expression in trigeminal and Rohon-Beard sensory neurons, the 4 kb islet1 
sensory neuron specific enhancer (Higashijima et al., 2000) was cloned upstream of the 
GAL4VP16 transcriptional activator (Koster and E, 2001), followed by 4xUAS:E1b 
minimal promoter-TRP channel-RFPT. The open reading frame was followed by an 
SV40 polyA sequence and cassette was flanked by ISce1 meganuclease sites and Tol2 
transposase arms. The Tg(islet1:GAL4VP16, 4xUAS:TRPV1-RFPT) and 
Tg(islet1:GAL4VP16, 4xUAS:TRPA1-RFPT) transgenic lines were generated using the 
ISce1 approach (Thermes et al., 2002). TRPM8 experiments used transient injection of an 
islet1:GAL4VP16, 4xUAS:TRPM8-RFPT transgene because we did not generate a stable 
transgenic line. The Tg(elavl3:GCaMP5G) (Portugues et al., 2013), 
Et(e1b:GAL4VP16)s1102t (Scott and Baier, 2009) and Tg(14xUAS:EGFP-Aequorin) 
(Naumann et al., 2010) transgenic lines have previously been described. 
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in situ hybridization and immunohistochemistry. Zebrafish samples were fixed in 4% 
paraformaldehyde/PBS for 12-16 hours at room temperature. Double fluorescent in situ 
hybridizations (ISH) were performed using digoxigenin (DIG) and 2,4-dinitrophenol 
(DNP)-labeled riboprobes and the TSA Plus DIG and DNP System (PerkinElmer, 
Wellesley, MA). An 818 bp template for the c-fos probe was amplified from a larval 
zebrafish cDNA library using the primers 5’- CAGCTCCACCACAGTGAAGA-3’ and 
5’- TGCAAACAATTCGCAAGTTC-3’. A 735 bp template for the rfpt probe was 
amplified from the TRPV1-RFPT plasmid using the primers 5’-
ATGGTGTCTAAGGGCGAAGA-3’ and 5’-TTACTTGTACAGCTCGTCCATG-3’. 
The islet-1 probe was generated as described (Higashijima et al., 2000). Samples were 
mounted in 50% glycerol in PBS, and imaged on a Zeiss LSM 780 laser-scanning 
confocal microscope with 488 nm and 561nm lasers and 10x, 25x and 40x objectives.  
 
Small molecule treatment. Frozen stock solutions of 100 mM Csn (M2028, Sigma) and 
500 mM Menthol (M2772, Sigma) were prepared by dissolving the compounds in 
dimethyl sulfide (DMSO). Working concentrations were prepared just prior to embryo 
treatment by diluting the stock solutions into E3 embryo medium (5 mM NaCl, 0.17 mM 
KCl, 0.33 mM CaCl2, 0.33 mM MgSO4, pH 7.4). All treatment conditions contained a 
final concentration of 0.2% DMSO. 
 
Temperature-dependent activation of TRPA1. Tg(islet1:Gal4VP16, UAS:TRPA1-
RFPT) transgenic larvae were raised in E3 medium at 22.5oC or 26.5oC to avoid 
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activating the TRPA1 channel. Embryos were transferred to E3 medium at temperatures 
up to 28.5oC to activate the channel. 
 
TRPV1-mediated cell ablation. For TRPV1-mediated Rohon-Beard cell ablation, 28 
hours post-fertilization (hpf) embryos were dechorionated and treated with 1 μM or 10 
μM Csn for 24 hours. Embryos were imaged just before Csn addition, and at 10 and 24 
hours after Csn addition. At each time point, each embryo was anesthetized with 0.03% 
tricaine and oriented on its side. Fluorescent images were acquired using a dsRed filter on 
a fluorescent stereomicroscope (M250c, Leica Microsystems Inc.) and a color CCD 
camera (DFC310FX, Leica Microsystems Inc.). Using ImageJ, fluorescence intensity was 
quantified in a 200 μm x 1.6 mm (28 hpf) or 100 μm x 2 mm (34 hpf and 48 hpf) region 
of interest that encompassed the dorsal spinal cord and most Rohon-Beard sensory 
neurons. Fluorescence intensity was calculated by subtracting background fluorescence 
from the measured fluorescence.  
 
Calcium imaging. Embryos at 2 days post-fertilization (dpf) were paralyzed with 1 
mg/ml α-bungarotoxin (2133, Fisher Scientific) dissolved in E3 medium and mounted on 
their side in 0.8% low melting point agarose in a 35 x 10 mm culture dish, and covered 
with 3 mL E3 medium. Tg(elavl3:GCaMP5G) fluorescence was imaged using a Zeiss 
780 confocal microscope with 20x dipping objective. Samples were excited with a 488 
nm laser and emitted light was collected through a 493-569 nm filter. For one-time 
activation by Csn experiments, images were acquired at 1 frame/second for 10 seconds 
before and 440 seconds after Csn application. Frame acquisition time was approximately 
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900 milliseconds. One mL of Csn at 4 µM, 12 µM, or 40 µM was added to the side of 
culture dish for a final concentration of 1 µM, 3 µM, or 10 µM, respectively. For repeated 
activation experiments, images were acquired at 1 frame/second for 10 seconds before 
and 290 seconds after Csn application. One mL of Csn at 4 µM was first added to the side 
of the dish for a final concentration of 1 µM. After imaging, Csn solution in the dish was 
washed out with E3 3 times for 5 minutes each. Same larva was imaged again using the 
same setting. One mL of Csn at 4 µM was again added to the side of the dish for a final 
concentration of 1 µM. GCaMP signal was imaged for 10 seconds before and 290 
seconds after Csn application. Fluorescence intensities were measured by drawing 
regions of interest around Rohon-Beard neurons using ImageJ. Change in fluorescence 
(ΔF/F0) was calculated as the fluorescence minus the initial fluorescence (defined as the 
mean fluorescence for the first 10 images) divided by initial fluorescence. A calcium 
transient is defined as at least 50% increase in ΔF/F0 from baseline. Average frequency of 
calcium transients was calculated by averaging the total number of calcium transients in 
each cell for each Csn concentration. Average amplitude of calcium transients was 
calculated by averaging the peak ΔF/Fo value of all calcium transients in each cell for 
each Csn concentration. Fractional changes in GCaMP response were calculated by 
averaging ΔF/Fo over 290s after Csn application for each cell. Prolonged calcium 
response is defined as any calcium transients lasting for more than 30s.  
 
Locomotor activity behavioral assay. Larval zebrafish were raised on a 14 hour:10 hour 
light:dark cycle at 28.5◦C (except for TRPA1+ larvae which were raised at 22oC) with 
lights on at 9 am and off at 11 pm. Individual larvae were placed into each well of a 96-
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well plate (7701-1651, Whatman) containing 650 µL E3 embryo medium. 2 dpf larvae 
were transferred into E3 medium containing Csn or vehicle control immediately before 
the start of behavioral recording at 12 pm. Locomotor activity was monitored using an 
automated videotracking system (Viewpoint Life Sciences) with a Dinion one-third inch 
Monochrome camera (Dragonfly 2, Point Grey) fitted with a variable-focus megapixel 
lens (M5018-MP, Computar) and infrared filter. The movement of each larva was 
recorded at 15 Hz, with an integration time of 1 second, using the quantization mode. 
One computer collected data from two cameras simultaneously. The 96-well plate and 
camera were housed inside a custom-modified Zebrabox (Viewpoint Life Sciences) that 
was continuously illuminated with infrared lights and illuminated with white lights from 
9 am to 11 pm. The 96-well plate was housed in a chamber filled with recirculating water 
to maintain a constant temperature of 28.5◦C (except for TRPA1+ larvae which were 
maintained at 25oC). The parameters used for detection were: detection threshold, 15; 
burst, 29; freeze, 3. Data were processed using custom PERL and Matlab (The 
Mathworks, Inc) scripts. Definitions of sleep/wake parameters were described previously 
(Prober et al., 2006). Statistical tests were performed using JMP and Matlab. 
 
Acridine orange staining. 24 hpf embryos were incubated in vehicle control, 1 µM or 10 
µM Csn for 8 hours. Then the embryos were transferred to 5 µg/mL acridine orange 
dissolved in E3 for 20 minutes in dark, followed with two 5-minute washes with E3. 
Images was acquired with a Zeiss 780 confocal microscope with 20x dipping objective 
using following settings: acridine orange – excited with a 488 nm laser and emitted light 
was collected through a 493-544 nm filter; TRPV1-RPPT – excited with a 561 nm laser 
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and emitted light was collected through a 624-659 nm filter. The bright field overlay 
show the position of the Rohon-Beard neurons along the spinal cord.   
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Supplemental figures  
 
 
 
Figure S3.1. Image series showing behavioral response to Csn activation of TRPV1-
expressing sensory neurons at 24hpf. Tg(islet1:GAL4VP16, 4xUAS-TRPV1-RFPT) 
embryos, but not their non-transgenic siblings, exhibit a robust behavioral response when 
immersed in 1 μM Csn. Images are captured at one second intervals after larvae were 
added to the dish. 
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Figure S3.2. Image series showing behavioral response to thermal activation of 
TRPA1-expressing sensory neurons at 48 hpf raised at 22 oC. Tg(islet1:GAL4VP16, 
4xUAS-TRPA1-RFPT) embryos, but not their non-transgenic siblings, exhibit a robust 
behavioral response when immersed in 27.5oC water after being maintained at 22.5oC. 
Images are captured at one second intervals after larvae were added to the dish. 
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Figure S3.3. Image series showing behavioral response to menthol activation of 
TRPM8-expressing sensory neurons at 24 hpf. Wild-type embryos injected with an 
islet1:GAL4VP16, 4xUAS-TRPM8-RFPT transgene, but not their uninjected siblings, 
exhibit a robust behavioral response when immersed in 300 μM menthol. Images are 
captured at one second intervals after larvae were added to the dish. 
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CHAPTER 4 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
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Conclusions 
 
This thesis uses larval zebrafish as a model to study circadian regulation of sleep 
in diurnal vertebrates. Chapter 2 characterizes the function of Prok2, a proposed circadian 
output molecule, in larval zebrafish (Cheng et al., 2002; Zhou and Cheng, 2005). The 
motivation behind the study is to better understand the role of Prok2 in regulating 
sleep/wake behavior in diurnal vertebrates, and to compare its function to that in 
nocturnal animals.  
I show that in larval zebrafish, Prok2 is expressed exclusively at the ventral 
hypothalamus, a region homologous to the mammalian SCN. Similar to nocturnal 
animals (Cheng et al., 2002; Li et al., 2006), Prok2 is required for normal sleep/wake 
behavior in larval zebrafish, and Prok2 overexpression is sufficient to modulate 
sleep/wake states. In addition, I discovered that Prok2 overexpression suppresses the 
predominant behavior induced by the lighting condition, and does not require an internal 
circadian clock. Furthermore, prok2-/- larvae exhibit hyperactivity and reduced sleep 
during the day. Combined with the genetic gain of function experiment, these results 
support a novel function of Prok2 acting as a homeostatic regulator to modulate and 
prevent hyperactivity in light in diurnal vertebrates.  
Unlike nocturnal rodents, prok2-/- larvae do not show attenuated circadian 
rhythmicity, as measured by sleep/wake behavior after removing external light cues. This 
discrepancy suggests that Prok2 may function differently in diurnal vs nocturnal animals. 
The role of Prok2 in regulation of circadian rhythm and sleep in humans has been 
reported in three studies. Two earlier studies reported that humans with a mutation in 
Prok2 experience sleep disorders, but did not specify which kind of sleep disorders (Dodé 
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et al., 2006; Cole et al., 2008). A recent study by Balasubramanina et al., reported that 
human patients with a loss of function mutation in Prok2 did not show abnormalities in 
central circadian rhythmicity, as measured by circulating cortisol and melatonin level, but 
exhibited impaired performance at the psychomotor vigilance task (Balasubramanian et 
al., 2014), which is often correlated to sleep deficit (Dinges et al., 1997; Van Dongen and 
Dinges, 2005). This observation is similar to the phenotype of prok2-/- larvae. prok2-/- 
larvae did not show changes in circadian rhythmicity measured by sleep/wake behavior 
after transitioning from regular light dark cycle into constant dark, but exhibit a change in 
homeostatic regulation of sleep during the day. One potential caveat to this explanation is 
that the measurement of central circadian rhythmicity is different in humans and 
zebrafish larvae. A more detailed characterization of sleep/wake behavior in human 
patients is needed to answer how sleep/wake behavior is affected. It is possible Prok2 
mediates circadian rhythmicity in sleep/wake behavior but not in the release of neuro-
endocrine molecules in humans. Nonetheless, the data on human patients so far agrees 
with the phenotype we observed in prok2-/- larvae, suggesting that larval zebrafish, being 
a diurnal vertebrate, may be a more appropriate model for studying circadian regulation 
of sleep for humans. In addition, this study also points out the potential difference of the 
function of circadian regulators between diurnal and nocturnal animals. Given the under-
representation of diurnal vertebrates used in sleep research, larval zebrafish may become 
an attractive model for studying circadian regulation of sleep in humans.  
Although Prok2 has been shown to bind to two receptors in vitro (Lin et al., 2002), 
Prok2 overexpression phenotype is specifically mediated by Prokr2 in vivo. prokr2 is 
expressed in several known sleep/wake centers in larval zebrafish, including the 
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noradrenergic locus coeruleus and histaminergic tuberomammillary nucleus. However, 
the Prok2 overexpression phenotype persisted in mutants that lack epinephrine, histamine 
or several other known sleep regulators (Table S2.1.), suggesting that Prok2 does not 
affect sleep via these neuromodulators. It remains possible that blocking more than one of 
these pathways simultaneously could inhibit the effects of Prok2 overexpression on sleep. 
Alternatively, Prok2 may act via known sleep regulatory pathways that were not tested or 
via unknown sleep regulators. Further characterization of Prok2 signaling or prok2-
expressing neurons could answer these questions (see future directions). 
   Chapter 3 focuses on expanding the existing repertoire of genetic tools to study 
behaviors using larval zebrafish. Several studies have successfully applied optogenetic 
tools to manipulate behavior in larval zebrafish (Douglass et al., 2008; Arrenberg et al., 
2009; Wyart et al., 2009); however, for behaviors like sleep/wake or visual response, a 
light stimulus may be inherently confounding (Zhu et al., 2009). To avoid the use of light, 
we wanted to test and adapt other pharmaco- and thermo- genetic tools to manipulate 
neuronal activity in larval zebrafish. In addition to the three TRP channels discussed in 
Chapter 3, I have also briefly tested Designer Receptors Exclusively Activated by 
Designer Drugs (DREADDs) developed by Bryan Roth’s group (Alexander et al., 2009) 
and Ligand Gated Ion Channels (LGICs) pioneered by Scott Sternson’s group (Magnus et 
al., 2011), by expressing them in the trigeminal sensory and Rohon-Beard neurons. 
However, none of these channels induced a behavior change similar to what was 
expected from activation of these neurons. In Chapter 3, I show that rat TRPV1, rat 
TRPM8, and rattlesnake TRPA1 can be used to activate neurons in larval zebrafish using 
their respective agonists. In addition, high Csn level can induce rapid ablation of TRPV1 
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expressing neurons. Other members in our lab have also successfully used TRPV1 to 
activate and ablate neurons in the lateral hypothalamus and dorsal raphe (unpublished 
data), suggesting that these channels successfully manipulate neuronal activity in deep 
brain structures in larval zebrafish. The characterization of the TRP channels offers a 
complementary set of genetic tools that can be used in combination with each other or 
with other genetic tools for studying behavior in larval zebrafish.  
 
Future directions 
 
Chapter 2 of this dissertation demonstrates that Prok2 can modulate sleep/wake 
behavior based on lighting conditions, and loss of Prok2 affects daytime activity and 
sleep levels. Further studies are needed to elucidate the mechanism by which Prok2 
signaling regulates sleep/wake behavior and the function of prok2-expressing neurons. 
The Prok2 overexpression phenotype persists in many known sleep regulator 
mutants (see Table 2.1). However, peptide overexpression may induce responses outside 
of the normal physiological range in animals. It may be more relevant to examine the 
sleep/wake behavior of prok2-/- larvae in these sleep regulator mutants. Another 
informative but brute force method of searching for the downstream regulator of Prok2 
signaling is to measure global changes in the transcriptome by RNA-seq analysis in 
Prok2 overexpression or loss of function mutants. It may be necessary to analyze 
transcript levels across multiple points in different lighting conditions. In addition, 
because activation of Prok receptors leads to activation of MAPK signaling pathway in 
vitro (Lin et al., 2002), measuring changes in protein phosphorylation upon Prok2 
overexpression or in prok2-/- mutants with proteomics analysis may be useful. Together, 
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these analyses may provide additional insights and identify new sleep regulatory regions 
to advance our understanding of sleep regulatory mechanisms.  
Based on our Prok2 gain and loss of function observations, we expect that 
activating prok2-expression neurons would suppress activity and promote sleep during 
the day, and increase activity and reduce sleep at night. In contrast, ablating or silencing 
prok2-expressing neurons would have the opposite effects on sleep/wake behavior. To 
test this hypothesis, we could utilize the TRP channels characterized in Chapter 3 to 
activate or ablate prok2-expressing neurons using a Prok2-specific enhancer. Other 
available genetic tools such as red shifted channelrhodopsin and enhance nitroreductase 
could be used as alternative methods for manipulating prok2-expressing neurons (Lin et 
al., 2013; Mathias et al., 2014). To look at the downstream target of prok2-expressing 
neurons, we could take advantage of the transparency of larval zebrafish and monitor 
global changes in neuronal activity in vivo (Ahrens et al., 2013).  We could activate 
prok2-expressing neurons by using one of above listed genetic tools and observe changes 
in GCaMP signal in the entire brain with light sheet microscopy. One particular region of 
interest is the LC, which is a known arousal center and expresses Prokr2 in larval 
zebrafish. Although Prok2 overexpression phenotype persisted in dbh-/- larvae, it is 
possible that the neurons of the LC, not just norepinephrine, are responsible for mediating 
Prok2 signaling.  
The availability of genetic tools could also be applied to combinatorial 
manipulation of neuronal populations in the brain. It would be interesting to look at the 
interaction between Prok2 with other proposed circadian output factors including TGF-α, 
CLC and AVP. Because all these peptides reduce locomotor activity in animals, they may 
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exhibit redundant function in transmitting the central circadian rhythmicity (Kramer et al., 
2001; Cheng et al., 2002; Kraves and Weitz, 2006; Li et al., 2009a). Simultaneous genetic 
silencing and activation of combinations of neurons expressing different circadian output 
factors may help to better characterize their distinctive functions.  
 
In summary, the work in this dissertation deepens our understanding of sleep 
regulation and establishes larval zebrafish as an alternative and appropriate model for 
studying circadian regulation of sleep in humans. With the expansion of existing genetic 
tools, future studies of circadian regulation of sleep and other behaviors in larval 
zebrafish may yield more insights about output from the master biological clock in 
humans.  
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APPENDIX 
 
GENERATION OF PROK2 AND PROK RECEPTOR MUTANTS  
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A powerful approach to determine the function of Prok2 is to mutate the 
corresponding genomic sequence to render it useless and analyze the mutant animals for 
behavioral changes. This section describes the generation of Prok2 and Prok receptor 
mutants used in Chapter 2 of the thesis. Two different genome editing methods were used 
and their efficacy in inducing somatic and germline mutation was compared. These data 
contributed to a larger dataset generated and published by our lab (Chen et al., 2013).  
 
Zinc Finger Nucleases (ZFNs) 
The first method we used to induce targeted mutation in the zebrafish is context-
dependent assembly (CoDA) generated ZFNs (Sander et al., 2011a). ZFNs can be 
designed to bind specific DNA sequences and induce double-strand DNA breaks (Urnov 
et al., 2010). Repair of ZFN-induced lesion by nonhomologous end joining often leads to 
deletion and insertion mutation at the site of lesion, creating frameshift mutation and 
premature stop codons in the targeted gene. Engineering ZFNs used to require either 
laborious selection process in bacteria or yeast system (Meng et al., 2008; Maeder et al., 
2009) or the use of preselected zinc finger modules which reports to have a low success 
rate (Ramirez et al., 2008; Urnov et al., 2010). CoDA, a publicly available platform, 
emerged as an alternative method and can generate ZFNs with high success rate and 
requires only standard cloning techniques (Sander et al., 2011a). Using ZiFIT Targeter 
(http://zifit.partners.org/ZiFiT), we designed CoDA generated ZFNs targeting Prok2 and 
both of the Prok receptors (Table A.1).  
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Gene Ensemble ID 
Site 
Position 
Left Target Right Target Spacer 
Prok2 ENSDARG00000091616 252-277 CGTACGTAG GCTGATGGC ACTACA 
Prokr1 ENSDARG00000074182 793-818 TCGCAGATG GGCGCAGAA GACGGC 
Prokr2 ENSDARG00000090315 854-878 GTGCCGAAT TCTGCTGGG TATCC 
 
 
Table A.1. ZFN target sites for Prok2 and Prok receptors. 
 
 
 
DNA fragments encoding zinc finger arrays were synthesized (Epoch Life 
Science, Inc) and cloned into FokI EL/KK heterodimeric expression vectors as previously 
described (Maeder et al., 2009).  
 
Transcription Activator-Like Effector Nucleases (TALENs) 
Because the DNA sequences that can be targeted using CoDA are limited (Sander 
et al., 2011a), we used TALENs as a second method for targeted mutagenesis in zebrafish. 
(Bogdanove and Voytas, 2011; Huang et al., 2011; Sander et al., 2011b). TALENs 
contain a variable number of 33-35 amino acid repeats, each of which preferentially binds 
to a specific nucleotide, and can be designed to target any DNA sequences. Two TALEN 
target sites for Prok2 and both Prok receptors were designed using the ZiFIT Targeter 
(http://zifit.partners.org/ZiFiT) based on published guidelines for optimal TALEN target 
sites (Cermak et al., 2011) (Table A.2).  
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Gene Ensemble ID 
Site 
Position 
Left Target Right Target Spacer 
Prok2 ENSDARG00000091616 102-151 
TGGCATGTG 
TTGTGCAGT 
AGTCTCCG 
AATGTGCA 
CAGTCTGT 
GGATCCGC 
Prok2 ENSDARG00000091616 7-55  
TCCAACATT 
TCTTTCTT 
GTGTCGCG 
TGGTTGGA 
TCTCTGCC 
TGCTGCTT 
Prokr1 ENSDARG00000074182 391-439  
TACTTGAGG 
ACTGTGTC 
AATGCTCT 
GCTGGCCA 
TCTCTACG 
TGTCCACC 
Prokr1 ENSDARG00000074182 73-124  
TATGACATC 
CCTGTGGAT 
ACGAAATTC 
CCGACACGA 
TACGAGGT 
CCCGGTGG 
Prokr2 ENSDARG00000090315 -16-36  
TCTCACAGA 
AACAGCCAT 
AGCCACGTG 
GCAGCTGTA 
GCAGGACG 
CCAATATC 
Prokr2 ENSDARG00000090315 94-146  
TACGACATG 
ATGGACTAC 
GATGCCGGA 
CACCACGCA 
GGGGTCCCG 
GCGGAGGA 
 
 
Table A.2. TALEN target sites for Prok2 and Prok receptors. 
 
TALE repeat arrays were constructed using the REAL Assembly TALEN kit and 
cloned into the wild type FokI expression vectors as previously described (Reyon et al., 
2012). 
 
TALENs are significantly more mutagenic than ZFNs in zebrafish 
Targeted mutagenesis in zebrafish using customized ZFNs and TALENs were 
performed as previously described (Foley et al., 2009). Briefly, ZFN and TALEN 
expression plasmids were linearized and used as template to generate mRNA followed by 
polyA tailing. Approximately 50-100 pg of each ZFN or TALEN mRNA pair was 
injected into the cell of zebrafish embryos at 1 cell stage. mRNA concentrations that were 
sufficient to cause developmental defects in 10-50% of injected embryos were used to 
analyze somatic mutation rate and generate germline mutants.  
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Detection of somatic and germline mutation has been described in detail (Chen et 
al., 2013). For somatic mutation, genomic DNA from 12 injected embryos for each ZFN 
and TALEN pair were prepared and amplified with PCR. The PCR products were then 
processed for deep sequencing with Illumina HiSeq2000. Indels were detected using 
SHRiMP2 software (David et al., 2011) and BLAT. For isolating germline mutants, 
zebrafish embryos injected with a ZFN or TALEN pair were raised to adulthood and 
mated to wild type fish. Genomic DNA was isolated from a pool of 1-6 embryos and 
targeted genomic regions were amplified using PCR with a reverse primer fluorescently 
labeled with 6-FAM. Fluorescent PCR products were run on an ABI 3730 DNA analyzer 
(Applied Biosystems) and analyzed using Peak Scanner (Applied Boisystems) to detect 
indels and identify injected F0 fish that carries germline mutation. 
We found that although both ZFNs and TALENs induced somatic mutation in 
vivo, TALENs induced somatic indels at much greater rate than ZFNs (Table A.3). The 
average somatic indel rate induced by tested ZFNs and TALENs were 1.21% and 8.90%, 
respectively. Furthermore, we found that TALENs can generate germline mutation much 
more efficiently than ZFNs. 37% of TALEN injected F0 fish contained germline 
mutation, but we failed to find any ZFN injected F0 fish contained germline mutation. 
Note that we did not characterize the germline mutation rate for Prok2 and Prokr1 
targeted by ZFNs because the somatic indel rate was much lower than that induced by 
TALENs. 
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Gene Ensemble ID 
Somatic Indel Rate (%) Germline Mutation Rate (%) 
TALEN 1 TALEN 2 ZFN 1 TALEN1 ZFN 
Prok2 ENSDARG00000091616 5.92 1.47 0.02 31 N/A 
Prokr1 ENSDARG00000074182 19.04 0.16 3.48 30 N/A 
Prokr2 ENSDARG00000090315 25.50 1.26 0.13 50 0.00 
 
 
Table A.3. Summary of somatic indel rate and germline mutation rate induced by 
ZFNs and TALENs. Somatic indel rate indicates the percentage of sequenced reads that 
contained mutation. Germline Mutation Rate indicates the percentage of injected F0 fish 
that contain mutations in their germline. N/A indicates no germline mutation rate was not 
characterized due to low somatic indel rate.  
 
 
 
In summary, this work demonstrates that TALENs are much more mutagenic than 
ZFNs in zebrafish. The observation is consistent with the larger dataset that our lab has 
generated after testing 84 ZFN pairs and 34 TALEN pairs. A detailed and statistically 
significant analysis of the efficacy for both genome editing methods can be found in the 
listed reference (Chen et al., 2013).  
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